fluphenazine has been researched along with haloperidol in 349 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 232 (66.48) | 18.7374 |
| 1990's | 56 (16.05) | 18.2507 |
| 2000's | 30 (8.60) | 29.6817 |
| 2010's | 24 (6.88) | 24.3611 |
| 2020's | 7 (2.01) | 2.80 |
| Authors | Studies |
|---|---|
| Bruderlein, FT; Humber, LG; Voith, K | 1 |
| Ellefson, CR; Kehr, JR; Miller, A; Woo, CM | 1 |
| George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Butler, DE; Coughenour, LL; DeWald, HA; Downs, DA; Heffner, TG; Lustgarten, D; Pugsley, TA; Wise, LD | 1 |
| Choudhary, MS; Craigo, SC; Meltzer, HY; Monsma, FJ; Roth, BL; Shen, Y; Sibley, DR; Uluer, A | 1 |
| Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J | 1 |
| Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Brouillette, WJ; Brown, GB; Zha, C | 1 |
| Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
| Balogh, I; Kim, HY; Koczok, K; Korade, Z; Liu, W; Mirnics, K; Porter, NA; Tallman, KA; Xu, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Rise, A | 1 |
| Friedman, E; Gershon, S; Rotrosen, J | 1 |
| Granacher, RP; Mason, AS | 1 |
| Heiss, WD; Hoyer, J; Thalhammer, G | 1 |
| Gochfeld, L; Klein, DF; Quitkin, F; Rifkin, A | 1 |
| Dencker, SJ | 1 |
| Hyttel, J | 2 |
| Dismukes, K; Mulder, AH | 1 |
| Di Chiara, G; Loddo, P; Spano, PF; Tonon, GC; Trabucchi, M | 1 |
| Bowers, MB; Rozitis, A | 1 |
| Hanin, I; Sherman, KA; Zigmond, MJ | 1 |
| Bowers, MB; Nelson, JC | 1 |
| Casu, M; Gessa, GL; Tissari, AH | 1 |
| Munday, KA; Poat, JA; Sumners, C; Woodruff, GN | 1 |
| Ambrosini, PJ; Nurnberg, HG | 1 |
| Kudrin, VS; Mineyeva, MF; Rayevsky, KS | 1 |
| Doss, FW | 1 |
| Charney, DS; Kales, A; Nelson, JC; Soldatos, CR | 1 |
| Kulhanek, F; Linde, OK; Meisenberg, G | 1 |
| Hirsch, SR | 1 |
| Bloss, JL; Singer, GH | 1 |
| Ahn, HS; Makman, MH | 1 |
| Arbuthnott, GW; Ungerstedt, U | 1 |
| Brown, JH; Makman, MH; Mishra, RK | 1 |
| Cools, AR; Gispen, WH; Wiegant, VM | 1 |
| Gruen, PH; Halpern, FS; Langer, G; Sachar, EJ | 1 |
| Martin, IC | 1 |
| Baker, GA; Blumenstein, J; Santalo, R | 1 |
| Ganguly, M; Kleinberg, DL; Schmidt, C; Weiss, G | 1 |
| Alvarez, C; Herlin, S; Raskind, M | 1 |
| Creese, I; Snyder, SH; Stewart, K | 1 |
| Costall, B; Hui, SC; Naylor, RJ | 1 |
| Berry, MS; MacDonald, JF | 1 |
| Kanno, Y; Muneoka, Y; Shiba, Y | 1 |
| Costall, B; Naylor, RJ | 4 |
| Caroli, F; Deniker, P; Ginestet, D; Littre-Poirier, MF | 1 |
| Ahn, HS; Demirjian, C; Makman, MH; Mishra, RK | 1 |
| Burnett, GB; Levenson, AJ; Nottingham, JD; Sermas, CE; Thornby, JI | 1 |
| Bockaert, J; Glowinski, J; Premont, J; Tassin, JP; Thierry, AM | 1 |
| Burt, DR; Creese, I; Snyder, SH | 1 |
| Staton, MA; Wallace, ER | 1 |
| Berger, PA; Davis, KL; De Fraites, EG | 1 |
| König, L | 1 |
| Gelenberg, AJ; Mandel, MR | 1 |
| König, L; Lange, E | 1 |
| Di Chiara, G; Spano, PF; Tonon, GC; Trabucchi, M | 1 |
| Davis, S; Itil, TM; Marasa, J; Mucciardi, AN; Saletu, B | 1 |
| Swett, C | 1 |
| Corbett, L | 1 |
| Burt, DR; Creese, I; Synder, SH | 1 |
| Stimmel, GL | 1 |
| Haffmans, PJ; Hoencamp, E; Jansen, GS | 1 |
| Chapman, MA; Klitenick, MA; See, RE | 1 |
| Sachdev, P; Tang, WM | 1 |
| Breier, A; Buchanan, RW; Carpenter, WT; Kirkpatrick, B; Maeda, K; Tamminga, CA | 1 |
| Cookson, JC; McLaren, S; Silverstone, T | 1 |
| Boutros, NN; Friesen, HG; Griffin, M; Peabody, CA; Warner, MD; Worsley, IG | 1 |
| Aravagiri, M; Chabert, N; Marder, SR; Van Putten, T; Wirshing, WC | 1 |
| Kirch, DG; McAllister, CG; Pickar, D; Rapaport, MH | 1 |
| Cookson, JC | 1 |
| Durst, R; Ghinea, C; Nir, I; Robinson, S; Rosca, P; Schmidt, U; Shai, U | 1 |
| Boyer, P; Lecrubier, Y; Puech, AJ | 1 |
| Angulo, JA; Cadet, JL; McEwen, BS | 1 |
| Ellison, G; See, RE | 1 |
| Kalugina, LI; Kopeĭko, GI; Kravchenko, NE; Mirzoian, MG; Ushakov, IuV | 1 |
| Schneider, T; Zrenner, E | 1 |
| Austin, MC; Kalivas, PW | 1 |
| Cooper, TB; Levinson, DF; Lo, ES; Simpson, GM; Stephanos, MJ; Yadalam, KG | 1 |
| Garver, DL; Thienhaus, OJ; Zemlan, FP | 1 |
| McCreadie, RG; Whitehead, A; Wiles, DH | 1 |
| Kubota, K; Matsumura, M; Sawaguchi, T | 1 |
| Hattori, K; Kobayashi, Y; Nakase, A; Yamada, K; Yamauchi, M | 1 |
| Aravagiri, M; Ellison, GD; See, RE | 1 |
| Gloersen, BA; Inderbitzin, LB; Lewine, RR; McDonald, SC; Rosen, PB; Vidanagama, BP | 1 |
| Angrist, B; Cooper, T; Douyon, R; Peselow, E; Rotrosen, J | 1 |
| Kakigi, T; Kaneda, H; Shintani, T; Tanimoto, K; Terada, T | 1 |
| Buchanan, RW; Carpenter, WT; Jauch, D; Kirkpatrick, B; Maeda, K; Tamminga, CA | 1 |
| Amrung, S; Davis, CM; Fidone, GS; Hernandez, JM; Jann, MW | 1 |
| Annable, L; Campbell, W; Chouinard, G | 1 |
| Brown, WA; Faraone, SV; Young, AS | 1 |
| Costall, B; Domeney, AM; Naylor, RJ | 1 |
| Madras, BK; Seeman, P | 1 |
| Achkova, P | 1 |
| Hietala, J | 1 |
| Carvey, P; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Gunne, LM; Häggström, JE | 1 |
| Beal, MF; Carr, DB; Fisher, J; Martin, JB | 1 |
| Simpson, GM; Yadalam, K | 1 |
| Gershon, S; McIntyre, IM | 1 |
| Domino, EF | 1 |
| Curry, SH | 1 |
| Lazarus, A | 1 |
| Schultz, W; Toan, DL | 1 |
| Knudsen, P | 1 |
| Jauregui, J; Kelley, AE; Nadaud, D; Stinus, L | 1 |
| Bowers, MB; Hoffman, FJ | 1 |
| Marder, SR; Van Putten, T | 1 |
| Jenner, P; Marsden, CD; Rupniak, NM | 1 |
| Salama, AI; Saller, CF | 1 |
| Cohen, BM; Lipinski, JF | 1 |
| Zetler, G | 1 |
| Bourin, M; Larousse, C; Poisson, L | 1 |
| James, WA; Pary, R; Tobias, CR; Turns, DM | 1 |
| Ellison, GD; Levin, ED; Levy, AD; See, RE | 1 |
| Dinan, TG | 1 |
| Bellodi, L; Brambilla, F; Brancato, V; Facchinetti, F; Genazzani, AR; Petraglia, F; Smeraldi, E | 1 |
| Addonizio, G; Alexopoulos, GS | 1 |
| Ellison, G; Gunne, L; Johansson, P; Levin, E; See, R | 1 |
| McMillen, BA | 1 |
| Amenta, F | 1 |
| Ellison, GD; Levin, ED; See, RE | 1 |
| Jamaluddin, J; Kyaw, O; Maniam, T | 1 |
| McCreadie, RG; McKane, JP; Robinson, AD; Stirling, GS; Wiles, DH | 1 |
| Capozzoli, JA; Coyle, JT; Joshi, PT | 1 |
| Walton, R | 1 |
| Cruse, RP; Erenberg, G; Rothner, AD | 1 |
| Rampertaap, MP | 1 |
| Wistedt, B | 1 |
| Cookson, JC; Gribbon, D; Kennedy, NM | 1 |
| Carvey, PM; Goetz, CG; Klawans, HL; Nelson, D; Tanner, CM | 1 |
| Daw, NW; Jensen, RJ | 3 |
| Antelman, SM; Edwards, DJ; Knopf, S; Kocan, D; Perel, JM; Stiller, R | 1 |
| Bruno, JP; Stricker, EM; Zigmond, MJ | 1 |
| Holt, RJ; Zengotita, HE | 1 |
| Drake, RE; Ehrlich, J | 1 |
| Kissling, W; Krueger, R; Möller, HJ; Trenk, D; Walter, K; Wittmann, B | 1 |
| Bonomo, V; Parisi, R; Rapisarda, V | 1 |
| Hartley, R; Padwick, D; Smith, JA | 1 |
| Kiloh, LG; Smith, JS; Williams, SE | 1 |
| Clement-Cormier, YC; Greengard, P; Kebabian, JW; Petzold, GL | 1 |
| Stern, P; Valjevac, K | 1 |
| Greenberg, D; Snyder, S; Yamamura, HI | 1 |
| Ciurezu, T; Cucu, I; Niturad, A | 1 |
| Manian, AA; Palmer, GC | 2 |
| Clemens, JA; Sawyer, BD; Smalstig, EB | 1 |
| Avrutskii, GIa; Gurovich, IIa; Prokhorova, IS; Romanov, IuD; Tirkel'taub, IuA | 1 |
| Gouret, C; Raynaud, G | 1 |
| Greenberg, D; Snyder, SH; Yamumura, HI | 1 |
| Mattsson, B; Persson, SA | 1 |
| Brown, JH; Makman, MH | 1 |
| Ban, TA; Lehmann, HE | 2 |
| Stille, G | 2 |
| Bordeleau, JM; Tétreault, L | 1 |
| Hertrich, O | 1 |
| Nielsen, IM | 1 |
| Heiss, WD; Hoyer, J | 1 |
| Anderson, WH; Kuehnle, JC | 1 |
| Lauener, H; Stille, G | 1 |
| Holden, JM; Itil, TM; Keskiner, A; Patterson, CD | 1 |
| Nymark, M | 1 |
| Boeck, V; Christensen, AV; Fjalland, B; Franck, KF; Nielsen, IM; Nymark, M; Pedersen, V | 1 |
| Fjalland, B; Moller Nielsen, I; Nymark, M; Pedersen, V | 1 |
| Baran, L; Maj, J; Sarnek, J; Sowińska, H | 1 |
| Hall, WB; Schiele, BC; Vestre, ND; Zimmermann, R | 1 |
| Soyka, D | 1 |
| Vichi, F | 1 |
| Holden, JM; Itil, TM; Keskiner, A | 1 |
| Campbell, EH; Hanson, HM; Itkin, AG; Witoslawski, JJ | 1 |
| Dillon, JB | 1 |
| Ayd, FJ | 1 |
| Demers, RG | 1 |
| Garriott, JC; Stolman, A | 1 |
| Goldberg, LI; Yeh, BK | 1 |
| Janssen, PA; Niemegeers, CJ; Verbruggen, FJ | 2 |
| Dooher, L; Dowling, J; Faretra, G | 1 |
| Dally, P | 1 |
| Malm, U | 1 |
| Schipper, JA | 1 |
| Janssen, PA; Lenaerts, FM; Niemegeers, CJ; Schellekens, KH | 1 |
| Glatzel, J | 1 |
| Brophy, JJ | 1 |
| Burchinsky, SG | 1 |
| Amenta, F; Cavallotti, C; Collier, WL; Iacopino, L | 1 |
| Schechter, MD | 1 |
| Bacopoulos, NG; Bustos, G; Redmond, DE; Roth, RH | 2 |
| Creese, I; DePaulo, JR; Slavney, PR; Snyder, SH; Tune, LE | 1 |
| Bridge, TP; DeLisi, LE; Karson, C; Morihisa, J; Potkin, SG; Rosenblatt, JE; Wagner, RL; Wise, CD; Wyatt, RJ | 1 |
| Freedman, R; Geller, HM; Hoffer, BJ; Marwaha, J | 1 |
| Davis, JM; Javaid, JI; Schaffer, CB; Shahid, A | 1 |
| Brown, WA; Laughren, TP; Williams, B | 1 |
| Blake, IM; Braddock, LE | 1 |
| Bracha, HS; Davis, KL; Kendler, KS | 1 |
| Brown, WA; Chisholm, E; Laughren, T; Williams, BW | 1 |
| Baron, M; Gruen, R; Kane, J; Levitt, M | 3 |
| Goetz, CC; Klawans, HL; Nausieda, PA; Tanner, CM; Weiner, WJ | 1 |
| Bourne, RC; Cross, AJ; Gamble, SJ; Waddington, JL | 1 |
| Mori, J; Satoh, H; Satoh, Y | 1 |
| Borison, RL; Diamond, BI | 1 |
| Eisenkraft, GJ; Shapiro, AK; Shapiro, E | 1 |
| Duncavage, MB; Goodnick, PJ; Meltzer, HY; Tong, C | 1 |
| DeHaven, DL; Halpern, EA; Lewis, MH; Mailman, RB | 1 |
| Davis, CM; Ereshefsky, L; Jann, MW; Richards, A; Saklad, SR; Seidel, DR | 1 |
| Alexander, P; Coyle, J; Kucharski, LT; Tune, L | 1 |
| Baldessarini, RJ; Cotton, P; Katz, B | 1 |
| Hershey, L; Rivera-Calimlim, L | 1 |
| Holt, RJ | 1 |
| Hansen, V; Jorgensen, A; Mackie, M; McCreadie, RG; Menzies, C; Wiles, DH | 1 |
| Fisher, A; Knezevic, W; Lefroy, RB; Mastaglia, FL | 1 |
| Beal, MF; Martin, JB | 1 |
| Asarnow, RF; Marder, SR; Van Putten, T | 1 |
| Davis, KL; Kendler, KS | 1 |
| Bacopoulos, NG | 2 |
| Luchins, DJ; Oliver, AP; Wyatt, RJ | 1 |
| Király, I; Van Ree, JM | 1 |
| Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
| de Mello, FG; de Mello, MC; Klein, WL; Paes de Carvalho, R; Ventura, AL | 1 |
| Puro, DG | 1 |
| Amenta, F; Collier, WL; De Rossi, M | 1 |
| Annable, L; Boisvert, D; Bradwejn, J; Campbell, W; Chouinard, G | 1 |
| Garbutt, JC; Loosen, PT | 1 |
| Cohen, BM; Zubenko, GS | 1 |
| Beckmann, H; Gattaz, D; Gattaz, WF; Reynolds, GP; Riederer, P | 1 |
| Ang, L; Borison, RL; Davis, JM; Diamond, BI; Hamilton, WJ | 1 |
| Carlsson, A; Gunne, LM; Häggström, JE; Wikström, H | 1 |
| Benson, DI; Kuhn, CM; Meyerson, LR; Stanley, M; Virgilio, J; Wazer, D | 1 |
| Biebl, W; Hinterhuber, H; Kienel, G; Mikuz, G; Platz, T | 1 |
| Ang, L; Borison, RL; Chang, S; Comaty, JE; Davis, JM; Dysken, M | 1 |
| Bacopoulos, NG; Baulu, J; Redmond, DE; Roth, RH | 1 |
| Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Waddington, JL | 1 |
| Hwu, HG; Nakra, BR | 1 |
| Boadle-Biber, MC | 1 |
| Delanoy, RL; Dunn, AJ | 1 |
| Roth, RH; Wheeler, SC | 1 |
| Furukawa, T; Yamada, K | 1 |
| Kamlana, SH; Kerry, RJ; Khan, IA | 1 |
| Kamiya, HO; Kohjimoto, Y; Takano, Y | 1 |
| Leelavathi, DE; Smith, RC | 1 |
| Freedman, R; Hoffer, B; Marwaha, J; Pittman, R | 1 |
| Arnt, J | 1 |
| Kassir, S; Parsons, B; Przedborski, S; Togasaki, DM | 1 |
| Amico, E; Goff, DC; Hubbard, JW; Midha, KK; Sarid-Segal, O | 1 |
| Misawa, M; Suzuki, T | 1 |
| Bravin, S; Invernizzi, G; Mantero, M; Mauri, MC | 1 |
| Baruah, S; Sherman, A; Waziri, R | 1 |
| Aravagiri, M; Hawes, EM; Hubbard, JW; Korchinski, ED; Marder, SR; McKay, G; Midha, KK | 1 |
| Bransgrove, LL; Kelly, MW | 1 |
| Ganguli, R; Nimgaonkar, VL; Silver, MA; Yang, ZW | 1 |
| Hubbard, JW; Marder, SR; Marshall, BD; Midha, KK; Van Putten, T | 1 |
| Morris, BJ; Simpson, CS | 1 |
| Buhrich, N; Hayman, J | 1 |
| Altamura, AC | 1 |
| Chen, JF; Weiss, B | 1 |
| Brauzer, B; Casey, DE; Davis, JM; Gierl, B; Hassan, M; Kane, JM; Marder, SR; Schooler, N | 1 |
| Burke, MA; McEvoy, JP; Ritchie, JC | 1 |
| Gamble, G; Greenstein, RA; McLellan, AT; Stone, AM | 1 |
| Akiyama, K; Hamamura, T; Kanzaki, A; Kondo, K; Kuroda, S; Miyanagi, K; Mutoh, S; Otsuki, S; Tsuchida, K; Ujike, H | 1 |
| Barbosa-Coutinho, LM; Barros, HM; Moraes, JT; Oliveira, MC | 1 |
| Bauer, U; Gallhofer, B; Gruppe, H; Krieger, S; Lis, S | 1 |
| Fukamauchi, F; Kito, S; Mataga, N; Miyoshi, R; Sakai, M; Semba, J | 1 |
| Crismon, ML; Dorson, PG; Pabis, DJ | 1 |
| Dhopesh, V; Gamble, G; Maany, I; Macfadden, A | 1 |
| Bunker, MT; Marken, PA; Ruehter, VL; Schneiderhan, ME | 1 |
| Oreland, L; Prince, JA; Yassin, MS | 1 |
| Charney, DS; Glazer, WM; Heninger, GR; Krystal, JH; Petrakis, IL; Price, LH; Sernyak, MJ; Woods, SW | 1 |
| Davidkova, G; Morabito, M; Weiss, B; Zhang, SP; Zhou, LW | 1 |
| Bailey, RK; Dralle, PW; Eschmann, AJ; Strauss, AJ; Wagner, RB | 1 |
| Conley, RR; Kelly, DL; Love, RC; Moore, DB; Sherr, JD | 1 |
| Arana, GW; Gerding, LB; Labbate, LA; Measom, MO; Santos, AB | 1 |
| Buljat, G; Dodig, G; Jelovac, N; Marovic, A; Miklic, P; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rucman, R; Seiwerth, S; Sikiric, P; Turkovic, B | 1 |
| Bradley, RJ; Dwyer, DS; Liu, Y | 1 |
| Barbosa-Coutinho, L; Messinger, HP; Oliveira, MC; Tannhauser, M | 1 |
| Maj, J; Rogóz, Z; Skuza, G | 1 |
| Begić, D; Hotujac, L; Jokić-Begić, N | 1 |
| Al-Sughayir, MA | 1 |
| Marder, SR; Pierre, JM; Saunders, CS; Wirshing, DA; Wirshing, WC | 1 |
| Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA | 1 |
| Bilici, M; Cakirbay, H; Guler, M; Tan, U; Tosun, M; Ulgen, M | 1 |
| DeQuardo, J; Gilani, S; Rajarethinam, R; Tancer, M | 1 |
| Miller, DD | 1 |
| Conley, RR; Kelly, DL; Love, RC; McMahon, RP | 1 |
| HAEFNER, H; KUTSCHER, I | 1 |
| BOISSIER, JR; SIMON, P | 1 |
| GAYRAL, L; ROUX, G; TURNIN, J | 1 |
| Andersen, J; Duncan, E; Dunlop, BW; Phillips, LS; Sternberg, M | 1 |
| Allahham, A; Mainwaring, DE; Marriott, J; Stewart, P | 1 |
| Buckley, PF; Emsley, RA; Goldstein, JM | 1 |
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| DYKYJ, R; NODINE, JH | 1 |
| Broll, K; Hess, L; Ibach, B; Perfahl, M; Pfeiff, L; Putzhammer, A | 1 |
| Barna, I; Gazdag, G; Iványi, Z; Tolna, J | 1 |
| Hajak, G; Ibach, B; Johann, M; Perfahl, M; Pfeiff, L; Putzhammer, A; Zitzelsberger, U | 1 |
| Dwyer, DS; Lu, XH | 1 |
| McEvoy, JP | 1 |
| Boshoven, W; Duncan, E; Dunlop, BW; Hamer, RM; Phillips, LS; Woolson, SL | 1 |
| Ascher-Svanum, H; Faries, D; Marder, SR; Montgomery, W; Shi, L; Zhu, B | 2 |
| Ascher-Svanum, H; Marcus, SC; Olfson, M | 1 |
| Alfirevic, Z; Degoricija, V; Vucicevic, Z; Vukicevic-Badouin, D | 1 |
| Dembler, T; Gallinat, J; Heinz, A; Juckel, G; Kahnt, T; Kienast, T; Knutson, B; Koslowski, M; Schlagenhauf, F; Wrase, J | 1 |
| Britvić, D; Ille, T; Stanković, Z; Vuković, O | 1 |
| Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R | 1 |
| Mihaljević-Peles, A; Mihanović, M; Sagud, M; Silić, A; Zivković, M | 1 |
| Citrome, L; Jaffe, A; Levine, J | 1 |
| Preskorn, SH | 1 |
| Goodwin, DG; Lindsay, DS; Strobl, JS | 1 |
| Popović, I; Popović, V; Ravanić, D; Stanojević, A; Stojanović, M; Vladejić, S | 1 |
| Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A | 1 |
| Chrisphonte, P; Ostroff, RB; Rosenheck, RA | 1 |
| Covell, NH; Essock, SM; Jackson, CT; McEvoy, JP; Rojas, IA; Schooler, NR; Stroup, TS | 1 |
| Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I | 1 |
| Kirk Morton, N; Zubek, D | 1 |
| Brown, PI; Johnson-Davis, KL; Juenke, JM; McMillin, GA; Urry, FM | 1 |
| Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T | 1 |
| Gibson, LE; Green, AI; Mesholam-Gately, RI; Seidman, LJ | 1 |
| Johnson-Davis, KL; Slawson, MH | 1 |
| Helfer, B; Klupp, E; Leucht, S; Rothe, PH; Samara, MT; Schneider-Thoma, J | 1 |
| Biback, C; Digiacomo, D; Fang, T; Kalia, A; Kennedy, JL; Lobo, D; Smart, K; Tatone, D; Zack, M | 2 |
| Bhattiprolu, AK; Brzustowicz, LM; Clarke, SG; Crosta, CM; Dudzinski, NR; Firestein, BL; Fu, AY; Hernandez, K; Moore, JC; Paradiso, KG | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Osman, E; Yıldız, M | 1 |
| Fujii, Y; Misawa, F; Takeuchi, H | 1 |
| Akazawa, M; Inada, K; Okada, Y | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
22 review(s) available for fluphenazine and haloperidol
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neuroleptic plasma levels.
Topics: Antipsychotic Agents; Biological Availability; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Perphenazine; Schizophrenia; Thiothixene | 1991 |
Blood levels of neuroleptics: state of the art.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Mental Disorders; Phenothiazines; Research Design; Thioridazine; Thiothixene | 1985 |
The strategy and value of neuroleptic drug monitoring.
Topics: Antipsychotic Agents; Chlorpromazine; Chromatography, Gas; Chromatography, Liquid; Fluphenazine; Forensic Medicine; Haloperidol; Humans; Patient Compliance; Perphenazine; Phenothiazines; Radioligand Assay; Schizophrenia; Thioridazine; Thiothixene; Trifluoperazine | 1985 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1986 |
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease Models, Animal; Drug Synergism; Dystonia; Fluphenazine; Haloperidol; Histamine H1 Antagonists; Levodopa; Mastication; Methyltyrosines; Movement Disorders; Parasympatholytics; Physostigmine; Primates; Rats | 1986 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors | 1986 |
Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.
Topics: Animals; Antipsychotic Agents; Butyrophenones; Chemical Phenomena; Chemistry; Chlorpromazine; Dibenzazepines; Extrapyramidal Tracts; Fluphenazine; Haloperidol; Haplorhini; Humans; Perphenazine; Phenothiazines; Promazine; Rats; Receptors, Cholinergic; Schizophrenia; Thioridazine; Triflupromazine | 1974 |
[Neuroleptics in experimental teratogenesis].
Topics: Abnormalities, Drug-Induced; Animals; Chick Embryo; Chlorpromazine; Fluphenazine; Haloperidol; Mice; Prochlorperazine; Rats; Reserpine; Tranquilizing Agents | 1968 |
Neurotransmitter receptors in the central nervous system and aging: pharmacological aspect (review).
Topics: Adenylyl Cyclases; Aging; Animals; Brain; Desipramine; Dopamine; Dopamine Antagonists; Female; Fluphenazine; Haloperidol; Humans; Male; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Cholinergic; Receptors, Dopamine; Receptors, GABA-A; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Serotonin; Reserpine; Scopolamine; Spiperone; Tetrahydronaphthalenes; Tissue Distribution; Tritium | 1984 |
Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
Topics: Adult; Antipsychotic Agents; Biological Availability; Chromatography; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Kinetics; Magnetic Resonance Spectroscopy; Male; Middle Aged; Psychotic Disorders; Radioimmunoassay; Radioligand Assay | 1984 |
Neuroleptic concentrations and clinical response.
Topics: Aging; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Drug Interactions; Fluphenazine; Haloperidol; Humans; Parasympatholytics | 1984 |
Metabolism of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research findings and clinical implications.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Thioridazine | 1993 |
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Topics: Antipsychotic Agents; Brain; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Plasma; Psychiatric Status Rating Scales; Schizophrenia | 1994 |
A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance.
Topics: Antipsychotic Agents; Biological Availability; Biotransformation; Brain; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Metabolic Clearance Rate; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 1993 |
Dose response of prophylactic antipsychotics.
Topics: Administration, Oral; Aftercare; Antipsychotic Agents; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Patient Compliance; Psychotherapy; Recurrence; Schizophrenia; Schizophrenic Psychology | 1993 |
[COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
Topics: Agranulocytosis; Autonomic Nervous System Diseases; Chemical and Drug Induced Liver Injury; Chlorpromazine; Chlorprothixene; Epilepsy; Fluphenazine; Haloperidol; Hemorrhagic Disorders; Hepatitis; Imipramine; Leukopenia; Movement Disorders; Pharyngitis; Phenothiazines; Psychoses, Substance-Induced; Psychotic Disorders; Reserpine; Thioridazine; Toxicology; Tranquilizing Agents; Triflupromazine | 1964 |
Risks versus benefits of different types of long-acting injectable antipsychotics.
Topics: Administration, Oral; Antipsychotic Agents; Fluphenazine; Haloperidol; Health Care Costs; Humans; Injections, Intramuscular; Microspheres; Quality of Life; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Refusal | 2006 |
CNS drug development. Part I: The early period of CNS drugs.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Central Nervous System Agents; Depressive Disorder; Drug Discovery; Fluphenazine; Haloperidol; History, 20th Century; History, 21st Century; Humans; Imipramine; Mental Disorders; Psychotic Disorders; Thioridazine | 2010 |
Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia.
Topics: Antipsychotic Agents; Drug Substitution; Fluphenazine; Haloperidol; Humans; Schizophrenia; Treatment Outcome | 2018 |
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
41 trial(s) available for fluphenazine and haloperidol
| Article | Year |
|---|---|
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Schizophrenia; Thioridazine; Trifluoperazine; Trifluperidol | 1975 |
Positive feedback of oestrogen on LH secretion in women in neuroleptic drugs.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Estradiol; Feedback; Female; Fluphenazine; Follicle Stimulating Hormone; Haloperidol; Humans; Luteinizing Hormone; Prolactin; Tranquilizing Agents | 1977 |
[Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Placebos; Psychotic Disorders; Recurrence; Substance Withdrawal Syndrome; Sulpiride; Tranquilizing Agents | 1975 |
Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
Topics: Acute Disease; Adolescent; Adult; Clinical Trials as Topic; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Remission, Spontaneous; Schizophrenia; Thiothixene; Time Factors | 1976 |
Computerized EEG: predictor of outcome in schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Computers; Drug Resistance; Electroencephalography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Placebos; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Thiothixene | 1975 |
Haloperidol in psychiatry.
Topics: Anxiety Disorders; Basal Ganglia Diseases; Clinical Trials as Topic; Dopamine Antagonists; Fluphenazine; Haloperidol; Humans; Psychotic Disorders; Tourette Syndrome | 1975 |
Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
Topics: Adult; Aged; Chronic Disease; Depression; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Social Behavior | 1992 |
Side effects during long-term treatment with depot antipsychotic medication.
Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Parkinson Disease, Secondary; Psychomotor Agitation; Recurrence; Schizophrenia | 1991 |
Treatment of positive and negative symptoms: pharmacologic approaches.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride | 1990 |
[Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
Topics: Antipsychotic Agents; Cost-Benefit Analysis; Fluphenazine; Haloperidol; Humans; Remission Induction; Schizophrenia | 1990 |
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
Topics: Adult; Aged; Biological Availability; Double-Blind Method; Female; Fluphenazine; Half-Life; Haloperidol; Humans; Male; Middle Aged; Prolactin; Radioimmunoassay; Schizophrenia | 1990 |
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1986 |
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Random Allocation; Schizophrenia | 1987 |
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1986 |
Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Topics: Adult; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia | 1986 |
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
Topics: Adult; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1985 |
Efficacy of haloperidol in drug refractory patients.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Phenothiazines; Psychotic Disorders; Reflex; Schizophrenia; Tranquilizing Agents; Trifluoperazine | 1967 |
Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
Topics: Alpha Rhythm; Chronic Disease; Clinical Trials as Topic; Computers; Electroencephalography; Female; Fluphenazine; Haloperidol; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Placebos; Procyclidine; Psychiatric Status Rating Scales; Sleep; Thiothixene; Time Factors | 1974 |
A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
Topics: Adult; Aged; Behavior; Chronic Disease; Clinical Trials as Topic; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Parasympatholytics; Personality Inventory; Schizophrenia | 1968 |
[The effect of psychopharmacological drugs and other central nervous system effecting drugs on experimental nystagmus].
Topics: Amitriptyline; Apomorphine; Aporphines; Barbiturates; Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Diazepam; Dimenhydrinate; Eye Movements; Fluphenazine; Haloperidol; Humans; Imipramine; Schizophrenia; Thioridazine; Triflupromazine | 1968 |
Assessment and significance of changes in laboratory values with haloperidol and fluphenazine hydrochloride therapy.
Topics: Adult; Clinical Trials as Topic; Computers; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Placebos; Schizophrenia | 1970 |
[Depot-neuroleptics in the treatment of schizophrenia].
Topics: Adult; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Perphenazine; Schizophrenia; Thioridazine | 1971 |
Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics.
Topics: Adult; Antipsychotic Agents; Attitude to Health; Clinical Trials as Topic; Clonidine; Drug Therapy, Combination; Female; Fluphenazine; Haloperidol; Humans; Male; Patient Dropouts; Pimozide; Tourette Syndrome | 1983 |
Neuroleptic drug-induced changes in platelet levels.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Platelet Count; Thrombocytopenia | 1984 |
A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Schizophrenia | 1984 |
A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics.
Topics: Adult; Borderline Personality Disorder; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Haloperidol; Humans; Personality Disorders; Thyrotropin-Releasing Hormone | 1984 |
Treatment approaches in Gilles de la Tourette syndrome.
Topics: Amantadine; Benztropine; Clonidine; Fluphenazine; Haloperidol; Humans; Lithium; Tourette Syndrome; Trifluoperazine | 1983 |
New pharmacological approaches in the treatment of Tourette syndrome.
Topics: Adolescent; Adult; Amantadine; Benztropine; Child; Clinical Trials as Topic; Clonidine; Female; Fluphenazine; Haloperidol; Humans; Lithium; Male; Tourette Syndrome; Trifluoperazine | 1982 |
A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia.
Topics: Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluphenazine; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1995 |
Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Brief Psychiatric Rating Scale; Female; Fluphenazine; Haloperidol; Homovanillic Acid; Humans; Male; Schizophrenia; Statistics, Nonparametric; Treatment Outcome | 1995 |
Naltrexone augmentation of neuroleptics in schizophrenia.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Schizophrenia | 1998 |
Quantitative EEG in schizophrenic patients before and during pharmacotherapy.
Topics: Adult; Antipsychotic Agents; Beta Rhythm; Delta Rhythm; Electroencephalography; Female; Fluphenazine; Fourier Analysis; Haloperidol; Humans; Male; Schizophrenia; Sulpiride | 2000 |
Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bone Density; Clopenthixol; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2002 |
Augmentation of clozapine partial responders with conventional antipsychotics.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Synergism; Fluphenazine; Haloperidol; Humans; Middle Aged; Schizophrenia; Treatment Outcome | 2003 |
Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Tolerance; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Quetiapine Fumarate; Schizophrenia | 2004 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
[Alterations of gait parameters under external cueing in schizophrenic patients: a switch study].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Exercise Test; Female; Flupenthixol; Fluphenazine; Gait; Haloperidol; Humans; Male; Middle Aged; Muscle Rigidity; Olanzapine; Schizophrenia | 2004 |
Performance of diadochokinetic movements in schizophrenic patients.
Topics: Analysis of Variance; Antipsychotic Agents; Biomechanical Phenomena; Case-Control Studies; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Fluphenazine; Functional Laterality; Haloperidol; Hand; Humans; Male; Movement; Psychiatric Status Rating Scales; Psychomotor Disorders; Psychomotor Performance; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Signal Processing, Computer-Assisted | 2005 |
First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Substitution; Female; Fluphenazine; Haloperidol; Hospitalization; Humans; Long-Term Care; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Serbia; Treatment Outcome | 2011 |
Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial.
Topics: Antipsychotic Agents; Connecticut; Delayed-Action Preparations; Drug Substitution; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Hyperprolactinemia; Injections; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Microspheres; Middle Aged; Patient Compliance; Proportional Hazards Models; Risperidone; Schizophrenia; Weight Gain | 2012 |
287 other study(ies) available for fluphenazine and haloperidol
| Article | Year |
|---|---|
Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Butaclamol; Catalepsy; Conditioning, Psychological; Dextroamphetamine; Dibenzocycloheptenes; Epinephrine; Humans; Male; Rats; Stereotyped Behavior; Structure-Activity Relationship | 1978 |
Synthesis and biological evaluation of some 2-amino-4-aryl-3H-1,5-benzodiazepine analogues of clozapine.
Topics: Adenylyl Cyclase Inhibitors; Animals; Antipsychotic Agents; Avoidance Learning; Brain; Clozapine; Corpus Striatum; Dextroamphetamine; Dibenzazepines; Dopamine; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mice; Rats | 1978 |
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Ataxia; Avoidance Learning; Brain; Cebus; Chemical Phenomena; Chemistry; Dopamine; Male; Mice; Motor Activity; Movement Disorders; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Saimiri | 1986 |
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
Topics: Animals; Antipsychotic Agents; Cell Line; Molecular Structure; Rats; Receptors, Serotonin | 1994 |
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship | 2009 |
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts.
Topics: Animals; Cell Line; Dehydrocholesterols; Dose-Response Relationship, Drug; Fibroblasts; Homeostasis; Humans; Mice; Molecular Conformation; Neurons; Oxidoreductases Acting on CH-CH Group Donors; Small Molecule Libraries; Sterols; Structure-Activity Relationship | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Neuroleptics].
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Female; Fluphenazine; Haloperidol; Humans; Maternal-Fetal Exchange; Perphenazine; Pregnancy; Prochlorperazine; Teratogens; Thioridazine; Triflupromazine | 1976 |
The search for the dopamine receptor: tribulations.
Topics: Chlorpromazine; Dialysis; Dopamine; Fluphenazine; Haloperidol; Hydrogen-Ion Concentration; Membranes, Artificial; Pimozide; Promethazine; Receptors, Drug; Temperature; Time Factors | 1975 |
Basic principles of rapid neuroleptization.
Topics: Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Fluphenazine; Haloperidol; Hospitalization; Humans; Hypotension, Orthostatic; Medical History Taking; Psychoses, Substance-Induced; Psychotic Disorders; Thiothixene; Tranquilizing Agents | 1976 |
Antipsychotic drugs and dopamine-mediated responses in Aplysia neurons.
Topics: Acetylcholine; Action Potentials; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; In Vitro Techniques; Membrane Potentials; Mollusca; Neurons; Phenothiazines; Receptors, Dopamine; Serotonin; Thioridazine | 1976 |
Tardive dyskinesia: are first signs reversible?
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prognosis; Remission, Spontaneous | 1977 |
High-dose treatment with neuroleptics in the acute phase of mental disease.
Topics: Antipsychotic Agents; Flupenthixol; Fluphenazine; Haloperidol; Humans; Mental Disorders; Perphenazine; Time Factors | 1976 |
Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics.
Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Flupenthixol; Fluphenazine; Haloperidol; Male; Mice; Receptors, Dopamine; Time Factors | 1977 |
Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
Topics: Animals; Antipsychotic Agents; Apomorphine; Chlorpromazine; Cocaine; Corpus Striatum; Dopamine; Electric Stimulation; Fluphenazine; Haloperidol; Male; Rats; Spiperone | 1977 |
Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Chlorpromazine; Dopamine; Fluphenazine; Haloperidol; In Vitro Techniques; Isoproterenol; Male; Norepinephrine; Rats; Substantia Nigra; Sulpiride | 1977 |
Brain homovanillic acid: regional changes following chronic antipsychotic drug administration.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Chlorpromazine; Clozapine; Drug Tolerance; Fluphenazine; Haloperidol; Homovanillic Acid; Male; Phenylacetates; Rabbits; Thioridazine; Time Factors | 1977 |
The effect of neuroleptics on acetylcholine concentration and choline uptake in striatum: Implications for regulation of acetylcholine metabolism.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain Chemistry; Cerebral Cortex; Choline; Corpus Striatum; Fluphenazine; Haloperidol; Male; Rats; Spiperone | 1978 |
Delusional unipolar depression: description and drug response.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antipsychotic Agents; Delusions; Depression; Female; Fluphenazine; Haloperidol; Humans; Imipramine; Male; Middle Aged; Perphenazine; Thioridazine; Thiothixene | 1978 |
Chronic haloperidol: tolerance to the stimulating effect on striatal tyrosine hydroxylase.
Topics: Animals; Corpus Striatum; Drug Tolerance; Fluphenazine; Haloperidol; Kinetics; Male; Rats; Stimulation, Chemical; Time Factors; Tyrosine 3-Monooxygenase | 1979 |
The effect of neuroleptic drugs on drinking induced by central administration of angiotensin or carbachol.
Topics: Angiotensin II; Animals; Antipsychotic Agents; Carbachol; Chlorpromazine; Clozapine; Dopamine; Drinking Behavior; Flupenthixol; Fluphenazine; Haloperidol; Injections, Intraperitoneal; Injections, Intraventricular; Male; Pimozide; Rats; Sulpiride | 1979 |
Urinary incontinence in patients receiving neuroleptics.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Brain; Chlorpromazine; Female; Fluphenazine; Haloperidol; Humans; Lithium; Male; Schizophrenia; Thiothixene; Urinary Incontinence | 1979 |
Neurochemical parameters in the hyperresponsive phase after a single dose of neuroleptics to mice.
Topics: Animals; Antipsychotic Agents; Binding, Competitive; Brain; Cell Membrane; Flupenthixol; Fluphenazine; Haloperidol; Kinetics; Male; Mice; Piperazines; Receptors, Drug; Thioxanthenes; Tissue Distribution | 1979 |
The effect of neuroleptics on brain tyrosine hydroxylase.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Brain; Clozapine; Fluphenazine; Haloperidol; Hypothalamus; Male; Promethazine; Rats; Tyrosine 3-Monooxygenase | 1978 |
The effect of antipsychotic drugs on body weight: a retrospective review.
Topics: Antipsychotic Agents; Body Weight; Fluphenazine; Haloperidol; Humans; Loxapine; Schizophrenia; Thioridazine; Thiothixene | 1979 |
Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Drug Therapy, Combination; Epilepsy; Female; Fluphenazine; Haloperidol; Humans; Lithium; Male; Middle Aged; Perphenazine; Schizophrenia; Somnambulism; Thioridazine; Thiothixene | 1979 |
Precipitation of antipsychotic drugs in interaction with coffee or tea.
Topics: Chemical Precipitation; Coffee; Drug Antagonism; Fluphenazine; Haloperidol; In Vitro Techniques; Tea | 1979 |
Precipitation of antipsychotic drugs in interaction with coffee or tea.
Topics: Chemical Precipitation; Coffee; Drug Antagonism; Fluphenazine; Haloperidol; Tea | 1979 |
Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.
Topics: Animals; Avoidance Learning; Behavior, Animal; Catalepsy; Clozapine; Dextroamphetamine; Fluphenazine; Haloperidol; Humans; Male; Mice; Motor Activity; Physostigmine; Prostaglandins E; Prostaglandins E, Synthetic; Rats; Stereotyped Behavior; Thioridazine | 1978 |
Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences.
Topics: Adenylyl Cyclases; Animals; Auditory Cortex; Brain; Caudate Nucleus; Dopamine; Drug Interactions; Fluphenazine; Frontal Lobe; Haloperidol; Haplorhini; Limbic System; Lysergic Acid Diethylamide; Macaca mulatta; Mescaline; Methamphetamine; Phentolamine; Receptors, Dopamine; Retina | 1979 |
Turning behavior induced by electrical stimulation of the nigro-neostriatal system of the rat.
Topics: Amphetamine; Animals; Brain Mapping; Caudate Nucleus; Corpus Striatum; Dopamine; Electric Stimulation; Fluphenazine; Haloperidol; Histocytochemistry; Microscopy, Fluorescence; Models, Neurological; Motor Activity; Neural Pathways; Phenoxybenzamine; Pimozide; Rats; Stimulation, Chemical; Substantia Nigra; Synaptic Transmission; Tetrabenazine | 1975 |
Cyclic AMP in retina and caudate nucleus: influence of dopamine and other agents.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Caudate Nucleus; Chlorpromazine; Cyclic AMP; Dopamine; Epinephrine; Ergotamine; Fluphenazine; Haloperidol; Isoproterenol; Lysergic Acid Diethylamide; Norepinephrine; Ouabain; Phentolamine; Potassium; Propranolol; Retina; Species Specificity | 1975 |
ACTH-induced excessive grooming involves brain dopamine.
Topics: Adrenocorticotropic Hormone; Animals; Brain; Caudate Nucleus; Dopamine; Drug Interactions; Fluphenazine; Grooming; Haloperidol; Injections; Male; Putamen; Rats; Rats, Inbred Strains; Stimulation, Chemical; Substantia Nigra | 1977 |
Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency.
Topics: Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Male; Perphenazine; Prochlorperazine; Prolactin; Schizophrenia; Synaptic Transmission; Thiothixene; Tranquilizing Agents; Trifluoperazine | 1977 |
Effect of psychotropic agents upon the blastogenic response of human t-lymphocytes.
Topics: Chlorpromazine; Depression, Chemical; DNA; Dopamine; Doxepin; Drug Synergism; Fluphenazine; Haloperidol; Humans; In Vitro Techniques; Lymphocyte Activation; Osmolar Concentration; Prochlorperazine; Proteins; RNA; T-Lymphocytes; Thiothixene; Thymidine; Tranquilizing Agents; Trifluoperazine; Uridine | 1977 |
Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
Topics: Aged; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1979 |
Species variation in dopamine receptor binding.
Topics: Animals; Apomorphine; Binding, Competitive; Brain; Cattle; Caudate Nucleus; Fluphenazine; Haloperidol; Humans; In Vitro Techniques; Male; Rats; Receptors, Dopamine; Species Specificity; Spiperone; Tetrahydronaphthalenes | 1979 |
Correlation between multitest and single test catalepsy assessment.
Topics: Animals; Catalepsy; Fluphenazine; Haloperidol; Humans; Male; Rats; Time Factors | 1978 |
Further identification of multiple responses mediated by dopamine in the CNS of Planorbis corneus.
Topics: Animals; Apomorphine; Central Nervous System; Dopamine; Evoked Potentials; Fluphenazine; Ganglia; Haloperidol; In Vitro Techniques; Lysergic Acid Diethylamide; Metoclopramide; Mollusca; Tubocurarine | 1978 |
Effects of neuroleptic drugs on the relaxing action of various monoamines in molluscan smooth muscle.
Topics: Amines; Animals; Fluphenazine; Haloperidol; Mollusca; Muscle Contraction; Muscle Relaxation; Muscle, Smooth | 1978 |
A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
Topics: Animals; Brain; Clozapine; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Extrapyramidal Tracts; Fluphenazine; Haloperidol; Limbic System; Male; Metoclopramide; Pimozide; Rats; Stereotaxic Techniques; Sulpiride; Thioridazine; Tranquilizing Agents | 1976 |
Catecholamine-sensitive adenylate cyclase in frontal cortex of primate brain.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Calcium; Catecholamines; Cerebral Cortex; Clozapine; Dopamine; Drug Combinations; Fluphenazine; Frontal Lobe; Guanosine Triphosphate; Haloperidol; Haplorhini; Isoproterenol; Macaca mulatta; Norepinephrine; Phentolamine; Receptors, Adrenergic; Receptors, Dopamine; Sodium Fluoride; Time Factors | 1976 |
Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
Topics: Adenylyl Cyclases; Animals; Cerebral Cortex; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Combinations; Fluphenazine; Frontal Lobe; Haloperidol; Isoproterenol; Male; Norepinephrine; Phentolamine; Propranolol; Rats; Receptors, Dopamine; Tranquilizing Agents | 1977 |
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.
Topics: Animals; Apomorphine; Corpus Striatum; Dextroamphetamine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Kinetics; Rats; Receptors, Dopamine; Reserpine; Time Factors; Tranquilizing Agents | 1977 |
Acute hypertension after abrupt withdrawal of antipsychotic medication.
Topics: Adolescent; Benztropine; Fluphenazine; Haloperidol; Humans; Hypertension; Male; Schizophrenia; Substance Withdrawal Syndrome; Trifluoperazine | 1977 |
Coexisting tardive dyskinesia and parkinsonism: a case report.
Topics: Acetylcholine; Adult; Benztropine; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Male; Parkinson Disease, Secondary; Physostigmine; Schizophrenia, Paranoid; Thioridazine; Tranquilizing Agents | 1977 |
[Long-term treatment with neuroleptics in schizophrenic and paraphrenic psychoses].
Topics: Delayed-Action Preparations; Depressive Disorder, Major; Fluphenazine; Haloperidol; Humans; Schizophrenia; Time Factors; Tranquilizing Agents | 1977 |
Catatonic reactions to high-potency neuroleptic drugs.
Topics: Adolescent; Adult; Amantadine; Catatonia; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Parkinson Disease, Secondary; Schizophrenia | 1977 |
[Significance and advantages of Orap in the ambulatory care of schizophrenic psychoses].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Cyclothymic Disorder; Depression; Depressive Disorder, Major; Female; Fluphenazine; Fluspirilene; Haloperidol; Humans; Male; Middle Aged; Penfluridol; Pimozide; Remission, Spontaneous; Schizophrenia; Therapeutic Equivalency | 1976 |
A dopamine-stimulated adenylate cyclase in rat substantia nigra.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Dopamine; Fluphenazine; Haloperidol; Isoproterenol; Male; Norepinephrine; Phentolamine; Propranolol; Rats; Stimulation, Chemical; Substantia Nigra | 1976 |
Drug-induced dystonia.
Topics: Adjustment Disorders; Adult; Basal Ganglia Diseases; Chlorpromazine; Chlorprothixene; Female; Fluphenazine; Haloperidol; Humans; Male; Mental Disorders; Mesoridazine; Middle Aged; Perphenazine; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Thioridazine; Thiothixene; Trifluoperazine | 1975 |
Technique of fluphenazine decanoate therapy in acute schizophrenic illnesses.
Topics: Acute Disease; Ambulatory Care; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluphenazine; Haloperidol; Hospitalization; Humans; Schizophrenia | 1975 |
Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Clozapine; Dextroamphetamine; Dibenzazepines; Dose-Response Relationship, Drug; Drug Synergism; Fluphenazine; Haloperidol; Humans; Isoquinolines; Male; Methyltyrosines; Pimozide; Rats; Spiro Compounds; Stereotyped Behavior; Succinimides; Sulpiride; Thioridazine; Tranquilizing Agents | 1975 |
The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.
Topics: Animals; Apomorphine; Binding, Competitive; Cattle; Caudate Nucleus; Cyproheptadine; Dopamine; Fluphenazine; Haloperidol; Lysergic Acid Diethylamide; Methiothepin; Receptors, Drug; Stereoisomerism | 1975 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloperidol; Humans; Levodopa; Models, Neurological; Movement Disorders; Parkinson Disease; Reserpine; Schizophrenia; Tranquilizing Agents; Trihexyphenidyl | 1976 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1992 |
Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats.
Topics: Animals; Antipsychotic Agents; Caudate Nucleus; Dialysis; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Nucleus Accumbens; Putamen; Rats; Rats, Sprague-Dawley | 1992 |
Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Infusions, Intravenous; Male; Neurologic Examination; Ocular Motility Disorders; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 1992 |
Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.
Topics: Administration, Oral; Adult; Brain; Dopamine; Fluphenazine; Haloperidol; Humans; Male; Prolactin; Psychiatric Status Rating Scales; Recurrence; Risk Factors; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Trifluoperazine | 1992 |
Prolactin bioassay in schizophrenia before and after neuroleptics.
Topics: Adult; Biological Assay; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prolactin; Radioimmunoassay; Schizophrenia; Schizophrenic Psychology; Thiothixene | 1992 |
The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness.
Topics: Adult; Antigens, Differentiation; Antipsychotic Agents; CD5 Antigens; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Lymphocyte Activation; Male; Schizophrenia; Schizophrenic Psychology; T-Lymphocytes; Thioridazine | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Fluphenazine; Haloperidol; Humans; Male; Melatonin; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1991 |
Effect of typical and atypical neuroleptic treatment on protachykinin mRNA levels in the striatum of the rat.
Topics: Animals; Antipsychotic Agents; Base Sequence; Corpus Striatum; Fluphenazine; Gene Expression Regulation; Haloperidol; Indoles; Male; Molecular Sequence Data; Molindone; Nucleic Acid Hybridization; Protein Precursors; Rats; RNA, Messenger; Tachykinins | 1990 |
Chronic administration of typical, but not atypical neuroleptics induce persisting alterations in rest-activity cycles in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Drinking; Female; Fluphenazine; Haloperidol; Motor Activity; Raclopride; Rats; Rats, Inbred Strains; Salicylamides | 1990 |
Effects of D-1 and D-2 dopamine antagonists on ERG and optic nerve response of the cat.
Topics: Animals; Cats; Electrophysiology; Electroretinography; Fluphenazine; Haloperidol; Optic Nerve; Receptors, Dopamine; Retina; Sulpiride | 1991 |
Dopaminergic involvement in locomotion elicited from the ventral pallidum/substantia innominata.
Topics: Animals; Biogenic Amines; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fluphenazine; Globus Pallidus; Haloperidol; Male; Motor Activity; Osmolar Concentration; Picrotoxin; Rats; Rats, Inbred Strains; Substantia Innominata | 1991 |
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Metabolic Clearance Rate; Psychotic Disorders | 1990 |
Length of psychiatric hospitalization and prediction of antipsychotic response.
Topics: Fluphenazine; Hallucinations; Haloperidol; Hospitalization; Humans; Length of Stay; Prognosis; Schizoid Personality Disorder; Schizophrenia; Schizophrenic Psychology; Thiothixene | 1990 |
Effects of dopamine antagonists on neuronal activity related to a delayed response task in monkey prefrontal cortex.
Topics: Animals; Behavior, Animal; Dopamine; Dopamine Antagonists; Fluphenazine; Frontal Lobe; Haloperidol; Male; Neurons; Sulpiride | 1990 |
Dopamine-induced relaxation in human pulmonary arteries.
Topics: Aged; Dinoprost; Domperidone; Dopamine; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Norepinephrine; Pulmonary Artery; Receptors, Dopamine; Receptors, Dopamine D1 | 1989 |
Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors.
Topics: Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A; Spiperone | 1989 |
Fluphenazine decanoate: a clinical problem?
Topics: Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Schizophrenia; Schizophrenic Psychology | 1989 |
Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
Topics: Adult; Alprazolam; Antipsychotic Agents; Basal Ganglia Diseases; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |
Comparison of prolactin responses to D-1 and D-2 antagonists in rats: Ro 22-1319 is a potent D-2 antagonist.
Topics: Animals; Antipsychotic Agents; Benzazepines; Domperidone; Fluphenazine; Haloperidol; Isoquinolines; Male; Perphenazine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1989 |
Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
Topics: Adult; Antipsychotic Agents; Brain; Female; Fluphenazine; Haloperidol; Humans; Male; Prolactin; Psychotic Disorders; Receptors, Dopamine; Schizophrenia; Substance Withdrawal Syndrome; Trifluoperazine | 1989 |
Clinical implications of increased antipsychotic plasma concentrations upon anticonvulsant cessation.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Intellectual Disability; Neurocognitive Disorders; Schizophrenia; Substance Withdrawal Syndrome | 1989 |
Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Blood-Brain Barrier; Brain; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Radioligand Assay; Schizophrenia; Schizophrenic Psychology; Thioridazine | 1989 |
Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
Topics: Animals; Apomorphine; beta-Endorphin; Callitrichinae; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Fluphenazine; Haloperidol; Injections; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei | 1989 |
Drug potencies on partially purified brain D2 dopamine receptors.
Topics: Animals; Butaclamol; Chlorpromazine; Corpus Striatum; Dogs; Fluphenazine; Haloperidol; Isoelectric Focusing; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Stereoisomerism; Time Factors | 1985 |
[Possibilities for research on the proton-acceptor action of drug preparations].
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dose-Response Relationship, Drug; Electric Conductivity; Fluphenazine; Haloperidol; In Vitro Techniques; Lipid Bilayers; Methods; Methotrimeprazine; Phospholipids; Protons; Solutions | 1987 |
Effects of DA-1- and DA-2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission.
Topics: Animals; Apomorphine; Blood Pressure; Domperidone; Dopamine Antagonists; Electric Stimulation; Fluphenazine; Haloperidol; Male; Peripheral Nerves; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction | 1988 |
The pathophysiology of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Guinea Pigs; Haloperidol; Humans; Receptors, Dopamine; Stereotyped Behavior; Thioridazine; Time Factors | 1985 |
Experimental tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Brain; Cebus; Corpus Striatum; Disease Models, Animal; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Fluphenazine; Frontal Lobe; gamma-Aminobutyric Acid; Globus Pallidus; Glutamate Decarboxylase; Haloperidol; Homovanillic Acid; Rats; Substantia Nigra | 1985 |
Effects of neuroleptic drugs on brain beta-endorphin immunoreactivity.
Topics: Animals; Antipsychotic Agents; beta-Endorphin; Brain Chemistry; Chlorpromazine; Corpus Striatum; Dopamine; Endorphins; Fluphenazine; Haloperidol; Limbic System; Male; Radioimmunoassay; Rats; Rats, Inbred Strains | 1985 |
Interpatient variations in antipsychotic therapy.
Topics: Age Factors; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Kinetics; Mental Disorders | 1985 |
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Macaca; Male; Motor Activity; Stereotyped Behavior; Substance Withdrawal Syndrome | 1985 |
Heatstroke in a chronic schizophrenic patient treated with high-potency neuroleptics.
Topics: Antipsychotic Agents; Benztropine; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Middle Aged; Schizophrenia | 1985 |
Responses of rat pallidum cells to cortex stimulation and effects of altered dopaminergic activity.
Topics: Animals; Cerebral Cortex; Dopamine; Fluphenazine; gamma-Aminobutyric Acid; Globus Pallidus; Glutamates; Glutamic Acid; Haloperidol; Male; Neural Pathways; Periodicity; Rats; Substantia Nigra; Synaptic Transmission | 1985 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines | 1985 |
Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens.
Topics: Animals; Antipsychotic Agents; Enkephalin, Methionine; Flupenthixol; Fluphenazine; Haloperidol; Male; Nucleus Accumbens; Perphenazine; Phenothiazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei; Sulpiride; Time Factors | 1986 |
Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration.
Topics: Animals; Antipsychotic Agents; Caudate Nucleus; Cerebral Cortex; Fluphenazine; Haloperidol; Homovanillic Acid; Male; Rats; Rats, Inbred Strains; Sulpiride; Time Factors | 1986 |
3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Buspirone; Carbazoles; Chlorpromazine; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Fluphenazine; Haloperidol; Male; Molindone; Pargyline; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Regression Analysis | 1986 |
In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.
Topics: Animals; Antipsychotic Agents; Binding, Competitive; Chlorpromazine; Clozapine; Fluphenazine; Haloperidol; Kinetics; Male; Prazosin; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Thioridazine | 1986 |
Antistereotype effects of ceruletide and some neuroleptics differentiated by interactions with clonazepam, muscimol, scopolamine and clonidine.
Topics: Animals; Antipsychotic Agents; Ceruletide; Clonazepam; Clonidine; Clopenthixol; Fluphenazine; Haloperidol; Male; Methylphenidate; Mice; Muscimol; Scopolamine; Sincalide; Stereotyped Behavior | 1986 |
Piracetam interactions with neuroleptics in psychopharmacological tests.
Topics: Amphetamines; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Drug Interactions; Fluphenazine; Haloperidol; Hypothermia; Male; Mice; Piracetam; Pyrrolidinones; Sulpiride | 1986 |
Depot neuroleptics for acutely psychotic patients.
Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders | 1987 |
Neuroleptic-induced oral movements in rats: methodological issues.
Topics: Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Methods; Mouth; Movement; Rats | 1987 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine | 1987 |
Effects of neuroleptic treatments on peripheral opioid secretion.
Topics: Adult; Antipsychotic Agents; beta-Endorphin; beta-Lipotropin; Chlorpromazine; Chronic Disease; Dibenzothiazepines; Drug Therapy, Combination; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Receptors, Opioid; Schizophrenia | 1987 |
Drug-induced dystonia in young and elderly patients.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Chlorpromazine; Dystonia; Female; Fluphenazine; Haloperidol; Humans; Male; Mental Disorders; Middle Aged; Retrospective Studies; Thiothixene | 1988 |
Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Dopamine Agents; Ergolines; Female; Fluphenazine; Haloperidol; Mouth; Quinpirole; Rats; Rats, Inbred Strains | 1988 |
Acute and subchronic effects of MJ-13859, a potential antipsychotic drug, on rat brain dopaminergic function.
Topics: Animals; Behavior, Animal; Binding Sites; Brain Chemistry; Dopamine; Female; Fluphenazine; Haloperidol; Metabolic Clearance Rate; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiro Compounds; Synaptic Transmission | 1985 |
Dopamine-sensitive adenylate cyclase in rabbit portal vein.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Dopamine; Female; Fluphenazine; Haloperidol; Male; Phentolamine; Portal Vein; Propranolol; Rabbits | 1985 |
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.
Topics: Animals; Female; Fluphenazine; Haloperidol; Mouth; Movement; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1988 |
Neuroleptic malignant syndrome--a study of 4 cases.
Topics: Adult; Autonomic Nervous System Diseases; Female; Fluphenazine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome | 1988 |
Low-dose neuroleptic therapy for children with childhood-onset pervasive developmental disorder.
Topics: Behavior Therapy; Child; Child Development Disorders, Pervasive; Drug Administration Schedule; Female; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Milieu Therapy; Psychological Tests; Substance Withdrawal Syndrome | 1988 |
More than mere shots.
Topics: Chronic Disease; Communication; Fluphenazine; Haloperidol; Humans; Mental Disorders; Patient Care Team; Psychiatric Aides; Psychiatric Nursing | 1988 |
The natural history of Tourette syndrome: a follow-up study.
Topics: Adaptation, Psychological; Adolescent; Adolescent Behavior; Adult; Aging; Clonidine; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Learning Disabilities; Tic Disorders; Tourette Syndrome | 1987 |
The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
Topics: Animals; Apomorphine; Behavior, Animal; Fluphenazine; Haloperidol; Male; Motor Activity; Rats; Receptors, Muscarinic; Stereotyped Behavior; Thioridazine | 1986 |
Effects of dopamine and its agonists and antagonists on the receptive field properties of ganglion cells in the rabbit retina.
Topics: Action Potentials; Animals; Apomorphine; Dopamine; Dopamine Antagonists; Flupenthixol; Fluphenazine; Haloperidol; Photic Stimulation; Rabbits; Reaction Time; Receptors, Dopamine; Retina; Retinal Ganglion Cells; Sulpiride; Visual Fields | 1986 |
Behavioral effects of a single neuroleptic treatment grow with the passage of time.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catalepsy; Corpus Striatum; Dopamine; Fluphenazine; Frontal Lobe; Haloperidol; Male; Nucleus Accumbens; Rats; Rats, Inbred Strains; Substantia Nigra; Time Factors | 1986 |
Rats given dopamine-depleting brain lesions as neonates are subsensitive to dopaminergic antagonists as adults.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Dopamine; Fluphenazine; Haloperidol; Hydroxydopamines; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains | 1985 |
Neuroleptic drug-induced coagulopathy: mechanism of reaction and duration of effect.
Topics: Adult; Blood Coagulation Disorders; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Partial Thromboplastin Time; Splenomegaly; Time Factors | 1986 |
Suicide attempts associated with akathisia.
Topics: Adult; Akathisia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Impulsive Behavior; Male; Psychomotor Agitation; Suicide, Attempted | 1985 |
Long-acting therapy of schizophrenia.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzodiazepines; Biofeedback, Psychology; Bromocriptine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Pimozide; Schizophrenia; Trimeprazine | 1985 |
The inhibition of pineal hydroxyindole-O-methyltransferase by haloperidol and fluphenazine.
Topics: Aminobutyrates; Animals; Cattle; Fluphenazine; Haloperidol; Humans; Indoles; Methyltransferases; Pineal Gland; Schizophrenia | 1972 |
Antiparkinson drugs as causal agents in tardive dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Benztropine; Drug Synergism; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Phenothiazines; Tropanes | 1973 |
Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Caudate Nucleus; Cricetinae; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Enzyme Activation; Fluphenazine; Guinea Pigs; Haloperidol; Humans; In Vitro Techniques; Isoproterenol; Kinetics; Mice; Olfactory Bulb; Pimozide; Rabbits; Rats; Species Specificity | 1974 |
The effect of phenothiazines on botulinus intoxication.
Topics: Animals; Antitoxins; Arachnida; Basal Ganglia Diseases; Botulinum Toxins; Botulism; Butyrophenones; Drug Synergism; Female; Fluphenazine; Haloperidol; Male; Perphenazine; Phenothiazines; Toxins, Biological; Trifluoperazine | 1974 |
Maintenance treatment of schizophrenia with long-acting fluphenazine.
Topics: Adult; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Movement Disorders; Phenothiazines; Piperazines; Schizophrenia | 1974 |
Modification of the receptor component of adenylate cyclase in the rat brain by phenothiazine derivatives.
Topics: Adenylyl Cyclase Inhibitors; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Brain; Brain Chemistry; Cerebral Cortex; Chlorpromazine; Cyclic AMP; Fluphenazine; Haloperidol; Hydroxylation; Hypothalamus; In Vitro Techniques; Male; Norepinephrine; Perphenazine; Prochlorperazine; Promazine; Rats; Receptors, Drug; Thiothixene; Tritium | 1974 |
The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
Topics: Amygdala; Animals; Behavior; Benzoates; Butyrophenones; Catalepsy; Dextroamphetamine; Dibenzazepines; Dibenzothiazepines; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Male; Metoclopramide; Piperidines; Rats; Stereotyped Behavior; Time Factors; Tranquilizing Agents | 1974 |
Antipsychotic drugs stimulate prolactin release.
Topics: Animals; Chlorpromazine; Dopamine; Female; Fluphenazine; Haloperidol; Male; Phenothiazines; Pimozide; Prolactin; Promethazine; Rats; Receptors, Drug; Sex Factors; Stimulation, Chemical; Sulpiride; Thiethylperazine; Thioridazine; Tranquilizing Agents | 1974 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorpromazine; Electroencephalography; Epinephrine; Female; Fluphenazine; Galvanic Skin Response; Haloperidol; Humans; Imipramine; Male; Middle Aged; Muscle Tonus; Perphenazine; Phenothiazines; Physical Exertion; Schizophrenia; Schizophrenia, Paranoid; Serotonin; Substance Withdrawal Syndrome; Syndrome; Tranquilizing Agents; Trifluoperazine; Trifluperidol | 1974 |
[Activity of various neuroleptics after single repeated treatment in the mice submitted to the four plate test and the escape test].
Topics: Animals; Chlorpromazine; Chlorprothixene; Diazepam; Drug Evaluation, Preclinical; Electroshock; Escape Reaction; Fluphenazine; Haloperidol; Methotrimeprazine; Mice; Perphenazine; Phenothiazines; Prochlorperazine; Thioridazine; Tranquilizing Agents; Trifluperidol | 1974 |
Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Chlorpromazine; Clozapine; Fluphenazine; Guinea Pigs; Haloperidol; Haplorhini; Humans; In Vitro Techniques; Perphenazine; Phenothiazines; Promazine; Rats; Receptors, Cholinergic; Schizophrenia; Thioridazine; Trifluoperazine; Triflupromazine | 1974 |
Cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid in huntington's chorea.
Topics: Adult; Chlormethiazole; Chlorpromazine; Female; Fluphenazine; Haloperidol; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Male; Methotrimeprazine; Middle Aged; Motor Activity; Perphenazine; Phenylacetates | 1974 |
Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina.
Topics: Adenylyl Cyclase Inhibitors; Animals; Apomorphine; Cattle; Chlorpromazine; Cyclic AMP; Dopamine; Enzyme Activation; Ergotamine; Fluphenazine; Haloperidol; Phentolamine; Phosphorus Isotopes; Propranolol; Retina; Tranquilizing Agents | 1973 |
Effects of phenothiazines and phenothiazine metabolites on adenyl cyclase and the cyclic AMP response in the rat brain.
Topics: Adenylyl Cyclase Inhibitors; Animals; Brain; Cerebral Cortex; Chlorpromazine; Cyclic AMP; Enzyme Activation; Fluphenazine; Haloperidol; Hydroxylation; Hypothalamus; In Vitro Techniques; Male; Neuroglia; Neurons; Norepinephrine; Perphenazine; Phenothiazines; Prochlorperazine; Promazine; Promethazine | 1974 |
[Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
Topics: Animals; Apomorphine; Arousal; Caudate Nucleus; Chlorpromazine; Chlorprothixene; Electroencephalography; Fluphenazine; Haloperidol; Humans; Methotrimeprazine; Perphenazine; Phenothiazines; Promazine; Rats; Reflex; Schizophrenia; Thioridazine; Tranquilizing Agents | 1969 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperidol; Humans; Mental Disorders; Methotrimeprazine; Movement Disorders; Parkinson Disease, Secondary; Phenothiazines; Promazine; Reserpine; Tranquilizing Agents; Trifluoperazine; Trihexyphenidyl | 1972 |
[Psychopharmacological therapy. 2. Neuroleptic agents].
Topics: Chemical Phenomena; Chemistry; Clopenthixol; Ethanol; Fluphenazine; Haloperidol; Humans; Models, Structural; Phenothiazines; Piperazines; Reserpine; Thiazines; Tranquilizing Agents; Xanthines | 1972 |
Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
Topics: Animals; Behavior, Animal; Chlorpromazine; Chlorprothixene; Clopenthixol; Dogs; Drug Evaluation, Preclinical; Drug Tolerance; Flupenthixol; Fluphenazine; Haloperidol; Mice; Motor Activity; Perphenazine; Rats; Tranquilizing Agents | 1974 |
Dopamine receptor blockade by neuroleptic drugs in Aplysia neurones.
Topics: Animals; Binding, Competitive; Dopamine; Dopamine Antagonists; Fluphenazine; Haloperidol; Mollusca; Neurons; Phenothiazines; Receptors, Drug | 1974 |
Strategies for the treatment of acute psychosis.
Topics: Acute Disease; Alcohol Amnestic Disorder; Cooperative Behavior; Emergencies; Female; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Neurologic Examination; Physical Examination; Psychotic Disorders; Remission, Spontaneous; Self Mutilation; Suicide; Time Factors; Trifluoperazine | 1974 |
[Effect of neuroleptic agents in the chronic pharmacological experiment].
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Corpus Striatum; Dibenzoxazepines; Drug Tolerance; Electroencephalography; Fluphenazine; Haloperidol; Homovanillic Acid; Humans; Piperazines; Rats; Sleep; Tranquilizing Agents | 1974 |
Mesolimbic involvement with behavioural effects indicating antipsychotic activity.
Topics: Animals; Behavior, Animal; Catalepsy; Dextroamphetamine; Dibenzothiazepines; Dose-Response Relationship, Drug; Electrodes, Implanted; Fluphenazine; Haloperidol; Humans; Limbic System; Male; Metoclopramide; Morphine; Piperidines; Rats; Spiro Compounds; Stereotaxic Techniques; Stereotyped Behavior; Tranquilizing Agents | 1974 |
Apomorphine provoked stereotype in the dog.
Topics: Amitriptyline; Animals; Anisoles; Apomorphine; Atropine; Behavior, Animal; Benzamides; Benztropine; Diazepam; Diphenhydramine; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Ethylamines; Female; Fluphenazine; Haloperidol; Humans; Male; Methyltyrosines; Motor Activity; Phenoxybenzamine; Piperazines; Receptors, Drug; Scopolamine; Stereotyped Behavior; Xanthenes | 1972 |
The comparative pharmacology of flupenthixol and some reference neuroleptics.
Topics: Animals; Avoidance Learning; Behavior, Animal; Body Temperature; Cats; Chlorpromazine; Chlorprothixene; Clopenthixol; Conditioning, Operant; Dogs; Drug Evaluation, Preclinical; Ethanol; Female; Fluphenazine; Guinea Pigs; Haloperidol; Isomerism; Male; Mice; Nictitating Membrane; Norepinephrine; Perphenazine; Piperazines; Rabbits; Rats; Structure-Activity Relationship; Tranquilizing Agents | 1973 |
Pharmacology of neuroleptics upon repeated administration.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Catalepsy; Cross Reactions; Dose-Response Relationship, Drug; Drug Tolerance; Ethanol; Fluphenazine; Germ-Free Life; Haloperidol; Humans; Male; Methylphenidate; Mice; Mice, Inbred Strains; Pimozide; Piperazines; Stereotyped Behavior; Thioxanthenes; Time Factors; Tranquilizing Agents | 1974 |
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
Topics: Amantadine; Animals; Apomorphine; Blood Pressure; Body Temperature; Brain Chemistry; Catalepsy; Chlorpromazine; Dextroamphetamine; Disulfides; Dopamine; Female; Fluphenazine; Haloperidol; Humans; Imidazoles; Male; Methyltyrosines; Motor Activity; Norepinephrine; Oxotremorine; Parasympatholytics; Rats; Reflex; Reserpine; Spiro Compounds; Stereotyped Behavior | 1974 |
Estimation of relative antiavoidance activity of depressant drugs in squirrel monkeys.
Topics: Animals; Avoidance Learning; Chlorpromazine; Conditioning, Operant; Fluphenazine; Haloperidol; Haplorhini; Hypnotics and Sedatives; Pentobarbital; Sympatholytics; Thioridazine | 1966 |
Parenteral long-acting phenothiazines.
Topics: Basal Ganglia Diseases; Fever; Fluphenazine; Haloperidol; Humans; Male; Middle Aged | 1972 |
Comparative trial of low dose haloperidol and fluphenazine in office patients.
Topics: Adult; Affect; Aged; Depression; Evaluation Studies as Topic; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Motor Activity; Neurotic Disorders; Schizophrenia; Social Behavior; Stress, Psychological | 1972 |
Psychosocial profiles and efficacy of lithium treatment.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Lithium; Male; Medical History Taking; Middle Aged; Schizophrenia; Social Behavior Disorders; Socioeconomic Factors; Suicide | 1971 |
Detection of some psychotherapeutic drugs and their metabolites in urine.
Topics: Amitriptyline; Amphetamine; Analgesics; Antidepressive Agents; Chlordiazepoxide; Chlorpromazine; Chromatography, Thin Layer; Desipramine; Diazepam; Fluphenazine; Haloperidol; Humans; Imipramine; Indicators and Reagents; Methadone; Perphenazine; Solvents; Thioridazine; Tranquilizing Agents; Trifluoperazine | 1971 |
Attenuation of dopamine-induced renal vasodilation in the dog by phenothiazines.
Topics: Animals; Bradykinin; Chlorpromazine; Dopamine; Dopamine Antagonists; Female; Fluphenazine; Haloperidol; Humans; Male; Phenothiazines; Prochlorperazine; Receptors, Drug; Regional Blood Flow; Renal Artery; Thioridazine; Trifluoperazine; Vasodilator Agents | 1971 |
The influence of various neuroleptic drugs on shock avoidance responding in rats. I. Nondiscriminated Sidman avoidance procedure.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Benperidol; Benzimidazoles; Butyrophenones; Chlorpromazine; Depression, Chemical; Electroshock; Escape Reaction; Female; Fluorine; Fluphenazine; Haloperidol; Isonipecotic Acids; Perphenazine; Piperidines; Promazine; Rats; Spiro Compounds; Thioridazine; Tranquilizing Agents; Trifluoperazine | 1969 |
Comparison of haloperidol and fluphenazine in disturbed children.
Topics: Aggression; Anxiety; Autistic Disorder; Child; Child, Preschool; Female; Fluphenazine; Haloperidol; Humans; Male; Psychotic Disorders; Schizophrenia, Childhood | 1970 |
The present status of psychotropic drugs.
Topics: Antidepressive Agents; Chlormethiazole; Diazepam; Dibenzazepines; Fluphenazine; Haloperidol; Humans; Hypnotics and Sedatives; Mental Disorders; Monoamine Oxidase Inhibitors; Neurotic Disorders; Propranolol; Schizophrenia | 1970 |
Intramuscular long-acting fluphenazine in the treatment of schizophrenia.
Topics: Administration, Oral; Adult; Aged; Chlorpromazine; Chronic Disease; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Methotrimeprazine; Middle Aged; Movement Disorders; Schizophrenia; Thioridazine; Trifluperidol | 1970 |
The influence of various neuroleptic drugs on noise escape response in rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Benperidol; Blepharoptosis; Butyrophenones; Catalepsy; Chlorpromazine; Escape Reaction; Female; Fluorine; Fluphenazine; Haloperidol; Humans; Noise; Perphenazine; Piperidines; Rats; Spiro Compounds; Thioridazine; Tranquilizing Agents; Trifluoperazine; Triflupromazine | 1970 |
Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and
Topics: Acepromazine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benperidol; Chlorpromazine; Chlorprothixene; Fluphenazine; Haloperidol; Male; Mastication; Methods; Motor Activity; Norepinephrine; Perphenazine; Phenothiazines; Prochlorperazine; Promazine; Rats; Thiazines; Thioridazine; Tranquilizing Agents; Trifluoperazine; Triflupromazine; Trimeprazine | 1967 |
[On the problem of the therapeutical axis symptom of neuroleptic medicaments].
Topics: Adult; Extrapyramidal Tracts; Fluphenazine; Haloperidol; Handwriting; Humans; Male; Movement Disorders; Psychotic Disorders | 1968 |
Single daily doses of neuroleptic drugs.
Topics: Chlorpromazine; Chlorprothixene; Chronic Disease; Dosage Forms; Fluphenazine; Haloperidol; Humans; Mental Disorders; Perphenazine; Piperazines; Schizophrenia; Tranquilizing Agents; Trifluoperazine | 1969 |
[Arousal inhibiting and catalepsy in neuroleptic drugs].
Topics: Animals; Arousal; Catalepsy; Chlorpromazine; Chlorprothixene; Fluphenazine; Haloperidol; Humans; Methotrimeprazine; Perphenazine; Rats; Tranquilizing Agents | 1966 |
Age-associated decrease of dopamine-sensitive adenylate cyclase in rabbit renal artery.
Topics: Adenylyl Cyclases; Age Factors; Animals; Cyclic AMP; Dopamine; Fluphenazine; Haloperidol; Male; Phentolamine; Pindolol; Rabbits; Receptors, Dopamine; Renal Artery | 1984 |
Effect of neuroleptics and tricyclic antidepressants upon d-amphetamine discrimination.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Chlorpromazine; Clozapine; Desipramine; Dextroamphetamine; Discrimination, Psychological; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Imipramine; Male; Nortriptyline; Promethazine; Rats; Sodium Chloride; Thioridazine; Trifluoperazine | 1980 |
Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Cerebral Cortex; Chlorocebus aethiops; Chlorpromazine; Dopamine; Fluphenazine; Haloperidol; Haplorhini; Homovanillic Acid; Humans; Neurons; Species Specificity; Time Factors | 1980 |
Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Molindone; Radioligand Assay; Schizophrenia; Thioridazine; Thiothixene; Trifluoperazine | 1981 |
A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Blood Platelets; Chronic Disease; Depression, Chemical; Female; Fluphenazine; Haloperidol; Humans; Male; Monoamine Oxidase; Schizophrenia; Trifluoperazine | 1981 |
Electrophysiologic interactions of antipsychotic drugs with central noradrenergic pathways.
Topics: Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Flupenthixol; Fluphenazine; Haloperidol; Male; Neural Pathways; Norepinephrine; Purkinje Cells; Rats | 1981 |
A case report of vomiting related to the interactions of antipsychotics and benztropine.
Topics: Adolescent; Antipsychotic Agents; Benztropine; Drug Interactions; Fluphenazine; Haloperidol; Humans; Male; Tropanes; Vomiting | 1981 |
Differential effects of neuroleptic agents on the pituitary-gonadal axis in men.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Luteinizing Hormone; Male; Middle Aged; Perphenazine; Prolactin; Testosterone; Thioridazine; Trifluoperazine | 1981 |
Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Pituitary Function Tests; Prolactin; Schizophrenia; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1981 |
Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
Topics: Animals; Antipsychotic Agents; Apomorphine; Fluphenazine; Haloperidol; Male; Metoclopramide; Mice; Molindone; Motor Activity; Receptors, Dopamine; Sulpiride; Synapses | 1982 |
Low serum neuroleptic levels predict relapse in schizophrenic patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Perphenazine; Recurrence; Schizophrenia; Schizophrenic Psychology; Thioridazine; Trifluoperazine | 1982 |
Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
Topics: Adult; Amine Oxidase (Copper-Containing); Antipsychotic Agents; Blood Platelets; Chlorpromazine; Female; Fluphenazine; Haloperidol; Humans; Male; Monoamine Oxidase; Oxidoreductases Acting on CH-NH Group Donors; Schizophrenia | 1982 |
Tourette-like symptoms following chronic neuroleptic therapy.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Female; Fluphenazine; Haloperidol; Humans; Time Factors; Tourette Syndrome; Trifluoperazine | 1982 |
Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
Topics: Adult; Antipsychotic Agents; Catechol O-Methyltransferase; Chlorpromazine; Chronic Disease; Erythrocytes; Female; Fluphenazine; Haloperidol; Humans; Male; Schizophrenia | 1982 |
Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Dopamine beta-Hydroxylase; Female; Fluphenazine; Haloperidol; Humans; Male; Schizophrenia | 1982 |
Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
Effect of zotepine and various drugs on apomorphine- and methamphetamine-induced rotational behaviour in rats with unilateral lesions of the substantia nigra.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Apomorphine; Atropine; Behavior, Animal; Diazepam; Dibenzothiepins; Fluphenazine; Haloperidol; Male; Methamphetamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1983 |
Regional selectivity of neuroleptic drugs: an argument for site specificity.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Corpus Striatum; Fluphenazine; Haloperidol; Limbic System; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thioridazine | 1983 |
Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Dopamine beta-Hydroxylase; Fluphenazine; Haloperidol; Humans; Schizophrenia; Thioridazine; Trifluoperazine | 1983 |
Serum effects confound the neuroleptic radioreceptor assay.
Topics: Animals; Antipsychotic Agents; Blood; Cattle; Chlorpromazine; Corpus Striatum; Female; Fluphenazine; Haloperidol; Humans; Male; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Drug; Thiothixene; Trifluoperazine | 1984 |
Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benztropine; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychotic Disorders; Radioligand Assay; Thiothixene | 1984 |
Dissimilar dosing with high-potency and low-potency neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Drug Utilization; Fluphenazine; Haloperidol; Hospitalization; Humans; Mental Disorders; Middle Aged; Risk; Schizophrenia; Thioridazine | 1984 |
Within-individual variation in steady state plasma levels of different neuroleptics and prolactin.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Pimozide; Prolactin; Schizophrenia | 1984 |
Neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Female; Fever; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Muscle Rigidity | 1984 |
Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Brain Chemistry; Chlorpromazine; Fluphenazine; Haloperidol; Male; Peptides; Pimozide; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Information processing and neuroleptic response in acute and stabilized schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Cognition; Fluphenazine; Haloperidol; Humans; Male; Pattern Recognition, Visual; Schizophrenia; Schizophrenic Psychology | 1984 |
Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Chlorpromazine; Fluphenazine; Haloperidol; Homovanillic Acid; Loxapine; Male; Metoclopramide; Molindone; Phenylacetates; Rats; Rats, Inbred Strains; Sulpiride | 1984 |
Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
Topics: Animals; Antipsychotic Agents; Brain; Butaclamol; Catalepsy; Dopamine; Fluphenazine; Haloperidol; Humans; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Spiperone | 1981 |
Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Chlorocebus aethiops; Dopamine; Female; Fluphenazine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Serotonin; Tyrosine 3-Monooxygenase | 1982 |
Neuroleptic-induced seizures. An in vitro technique for assessing relative risk.
Topics: Animals; Antipsychotic Agents; Butaclamol; Chlorpromazine; Culture Techniques; Dose-Response Relationship, Drug; Fluphenazine; Guinea Pigs; Haloperidol; Hippocampus; Male; Molindone; Pimozide; Seizures; Thioridazine | 1982 |
Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; beta-Endorphin; Bromocriptine; Dopamine; Endorphins; Ergolines; Fluphenazine; gamma-Endorphin; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Sulpiride | 1984 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
Regulation of dopamine- and adenosine-dependent adenylate cyclase systems of chicken embryo retina cells in culture.
Topics: Adenosine; Adenylyl Cyclases; Animals; Cells, Cultured; Chick Embryo; Chickens; Cyclic AMP; Darkness; Dopamine; Fluphenazine; Haloperidol; Kinetics; Receptors, Dopamine; Retina | 1982 |
Cholinergic transmission by embryonic retinal neurons in culture: inhibition by dopamine.
Topics: Acetylcholine; Animals; Animals, Newborn; Cells, Cultured; Cholinergic Fibers; Dopamine; Fluphenazine; Haloperidol; Neural Inhibition; Rats; Retina; Synaptic Transmission | 1983 |
Dopamine-sensitive adenylate-cyclase in rabbit superior mesenteric artery.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Female; Fluphenazine; Haloperidol; In Vitro Techniques; Male; Mesenteric Arteries; Phentolamine; Pindolol; Rabbits; Receptors, Dopamine; Theophylline | 1984 |
In vitro effects of psychotropic agents on the microviscosity of platelet membranes.
Topics: Blood Platelets; Blood Viscosity; Cell Membrane; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Imipramine; In Vitro Techniques; Lithium; Psychotropic Drugs; Spectrometry, Fluorescence | 1984 |
Effects of dopamine antagonists on receptive fields of brisk cells and directionally selective cells in the rabbit retina.
Topics: Animals; Dopamine Antagonists; Flupenthixol; Fluphenazine; Haloperidol; Metoclopramide; Rabbits; Receptors, Dopamine; Retina; Retinal Ganglion Cells; Sulpiride | 1984 |
Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients.
Topics: Adult; Chlorpromazine; Dopamine; Fluphenazine; Haloperidol; Humans; Male; Norepinephrine; Schizophrenia, Paranoid; Schizophrenic Psychology | 1983 |
Towards an understanding of the role of dopamine in the mammalian retina.
Topics: Action Potentials; Animals; Dopamine; Dopamine Antagonists; Evoked Potentials, Visual; Fluphenazine; Haloperidol; Motion Perception; Picrotoxin; Rabbits; Retina; Retinal Ganglion Cells; Vision, Ocular | 1983 |
Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias.
Topics: Animals; Cebus; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Male; Piperidines; Stereoisomerism | 1983 |
Lack of potency of metoclopramide's metabolites in various dopaminergic models.
Topics: Animals; Apomorphine; Dopamine; Fluphenazine; Haloperidol; Homovanillic Acid; Humans; Male; Metoclopramide; Prolactin; Rats; Rats, Inbred Strains; Spiperone; Stereotyped Behavior; Tetrahydronaphthalenes | 1983 |
[Vascular damage in intravenous infusion therapy with high-potency neuroleptics].
Topics: Animals; Aorta, Abdominal; Dose-Response Relationship, Drug; Endothelium; Fluphenazine; Haloperidol; Infusions, Parenteral; Rats; Rats, Inbred Strains; Thrombophlebitis | 1984 |
Chronic haloperidol or fluphenazine: effects on dopamine metabolism in brain, cerebrospinal fluid and plasma of Cercopithecus aethiops (vervet monkey).
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Cercopithecus; Dopamine; Female; Fluphenazine; Haloperidol; Haplorhini; Homovanillic Acid; Male | 1980 |
Compressive neuropathies in Tourette syndrome.
Topics: Adolescent; Adult; Female; Fluphenazine; Haloperidol; Humans; Male; Nerve Compression Syndromes; Tourette Syndrome | 1982 |
Tardive dyskinesia, fluphenazine decanoate, and haloperidol.
Topics: Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans | 1982 |
Catatonic-like syndrome during neuroleptic therapy.
Topics: Aged; Catatonia; Female; Fluphenazine; Haloperidol; Humans | 1982 |
Further studies on the role of calcium in the depolarization-induced activation of tryptophan hydroxylase. Effect of verapamil, Tetracaine, haloperidol and fluphenazine.
Topics: Animals; Brain Stem; Buffers; Calcium; Enzyme Activation; Fluphenazine; Haloperidol; Male; Membrane Potentials; Potassium; Rats; Rats, Inbred Strains; Tetracaine; Tryptophan Hydroxylase; Verapamil | 1982 |
Effects of haloperidol and apomorphine on catecholamine metabolism in brain slices. Reserpine-like effects of haloperidol.
Topics: Animals; Apomorphine; Brain Chemistry; Catecholamines; Chlorpromazine; Dopamine; Fluphenazine; Haloperidol; Male; Mice; Nerve Tissue Proteins; Reserpine | 1982 |
Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Fluphenazine; Haloperidol; Homovanillic Acid; Humans; Male; Olfactory Bulb; Rats; Receptors, Dopamine; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors | 1980 |
Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
Topics: Aminooxyacetic Acid; Animals; Antiparkinson Agents; Catalepsy; Delayed-Action Preparations; Drug Synergism; Enkephalins; Fluphenazine; Haloperidol; Humans; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1982 |
Lithium: some drug interactions.
Topics: Adult; Drug Interactions; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Lithium; Male; Middle Aged | 1980 |
Biochemical mechanism of tolerance to neuroleptic drugs; regional differences in rat brain.
Topics: Animals; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Dopamine; Drug Tolerance; Fluphenazine; Haloperidol; Homovanillic Acid; Rats; Spiperone | 1981 |
Effect of psychoytopic drugs on high affinity choline uptake by excised tissue of rat nucleus caudatus.
Topics: Animals; Apomorphine; Caudate Nucleus; Choline; Fluphenazine; Haloperidol; Male; Rats; Receptors, Dopamine | 1980 |
Chronic neuroleptics and brain monoamine oxidase activity.
Topics: Animals; Brain; Cerebral Cortex; Fluphenazine; Haloperidol; Hippocampus; Monoamine Oxidase; Rats; Rats, Inbred F344 | 1980 |
Age-related electrophysiological changes in rat cerebellum.
Topics: Aging; Amphetamine; Animals; Cerebellum; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Locus Coeruleus; Male; Neural Inhibition; Norepinephrine; Purkinje Cells; Rats | 1980 |
Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine.
Topics: Animals; Antipsychotic Agents; Clozapine; Dextroamphetamine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Imidazoles; Indoles; Locomotion; Male; Motor Activity; Prazosin; Rats; Rats, Wistar; Ritanserin | 1995 |
Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Binding Sites; Binding, Competitive; Corpus Striatum; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Sulpiride; Up-Regulation | 1995 |
Sertindole antagonizes morphine-, cocaine-, and methamphetamine-induced place preference in the rat.
Topics: Animals; Antipsychotic Agents; Cocaine; Conditioning, Operant; Fluphenazine; Haloperidol; Imidazoles; Indoles; Male; Methamphetamine; Morphine; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Spatial Behavior | 1995 |
Depression in schizophrenia: clinical and pharmacological variables.
Topics: Adolescent; Adult; Age Factors; Aged; Depressive Disorder; Dexamethasone; Female; Fluphenazine; Haloperidol; Humans; Hydrocortisone; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Severity of Illness Index | 1995 |
Neuroleptic effects on serine and glycine metabolism.
Topics: Adult; Animals; Antipsychotic Agents; Brain; Cytosol; Female; Fluphenazine; Glycine; Glycine Hydroxymethyltransferase; Haloperidol; Humans; Liver; Male; Mitochondria, Liver; Psychiatric Status Rating Scales; Rabbits; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Serine | 1993 |
Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Medical Records; Middle Aged; Time Factors | 1994 |
An inhibitory effect of psychoactive drugs on a human neuroblastoma cell line.
Topics: Antipsychotic Agents; Cell Division; Cell Line; Dose-Response Relationship, Drug; Flupenthixol; Fluphenazine; Haloperidol; Humans; Neuroblastoma; Tumor Cells, Cultured | 1994 |
Haloperidol and fluphenazine induce junB gene expression in rat striatum and nucleus accumbens.
Topics: Animals; Corpus Striatum; Fluphenazine; Gene Expression; Genes, Immediate-Early; Genes, jun; Haloperidol; In Situ Hybridization; Male; Neurons; Nucleus Accumbens; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger; Transcription, Genetic | 1994 |
Self-inflicted enucleation of both eyes.
Topics: Adult; Eye Enucleation; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Religion and Psychology; Schizophrenia, Paranoid; Self-Injurious Behavior | 1994 |
Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Base Sequence; Blotting, Northern; Clozapine; Corpus Striatum; Depression, Chemical; Dopamine D2 Receptor Antagonists; Fluphenazine; Glutamate Decarboxylase; Haloperidol; In Vitro Techniques; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA Probes; RNA, Messenger | 1993 |
A pilot study of a structured interview addressing sexual function in men with schizophrenia.
Topics: Adult; Basal Ganglia Diseases; Fluphenazine; Haloperidol; Hospitalization; Humans; Libido; Male; Masturbation; Penile Erection; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sexual Behavior; Surveys and Questionnaires | 1994 |
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
Topics: Adult; Ambulatory Care; Chronic Disease; Cocaine; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Substance-Related Disorders; Veterans | 1993 |
Effect of estrogen and neuroleptics on prolactin secretion and immunoreactive prolactin cells.
Topics: Animals; Antipsychotic Agents; Estrogens; Fluphenazine; Haloperidol; Male; Metoclopramide; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Sulpiride | 1996 |
Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.
Topics: Clozapine; Cognition; Fluphenazine; Haloperidol; Humans; Maze Learning; Risperidone; Schizophrenia | 1996 |
Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Brain; Clozapine; Corpus Striatum; Fluphenazine; Genes, fos; Haloperidol; In Situ Hybridization; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Quinolones; Rats; RNA, Messenger; Septum Pellucidum; Sulpiride | 1996 |
Evaluation of inpatient depot antipsychotic prescribing.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Drug Administration Schedule; Female; Fluphenazine; Haloperidol; Hospitals, Psychiatric; Humans; Inpatients; Male; Middle Aged; Prospective Studies | 1996 |
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia | 1997 |
Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Topics: Adolescent; Amenorrhea; Antipsychotic Agents; Bromocriptine; Clozapine; Female; Fluphenazine; Galactorrhea; Haloperidol; Humans; Hyperprolactinemia; Prolactin; Psychotic Disorders; Thioridazine | 1997 |
A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics.
Topics: Animals; Antipsychotic Agents; Brain; Clozapine; Densitometry; Electron Transport Complex IV; Fluphenazine; Haloperidol; Histocytochemistry; Male; Rats; Rats, Sprague-Dawley | 1998 |
D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Tolerance; Fluphenazine; Genetic Vectors; Grooming; Haloperidol; Male; Mice; Quinpirole; Receptors, Dopamine D2; RNA, Antisense; Stereotyped Behavior; Up-Regulation | 1998 |
Conventional psychotropic-induced tremor extinguished by olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Fluphenazine; Haloperidol; Humans; Male; Mental Disorders; Olanzapine; Pirenzepine; Tremor | 1998 |
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone.
Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Patient Readmission; Risperidone; Schizophrenia; Time Factors | 1998 |
Alcohol dependence and hospitalization in schizophrenia.
Topics: Adult; Alcoholism; Antipsychotic Agents; Cocaine-Related Disorders; Comorbidity; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Marijuana Abuse; Middle Aged; Patient Readmission; Retrospective Studies; Risk Factors; Schizophrenia; Treatment Refusal | 1999 |
Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.
Topics: Animals; Anti-Ulcer Agents; Antipsychotic Agents; Catalepsy; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Fluphenazine; Haloperidol; Male; Mice; Orientation; Peptic Ulcer; Peptide Fragments; Proteins; Rats; Rats, Wistar; Sulpiride; Time Factors | 1999 |
Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Benzazepines; Biological Transport; Chlorpromazine; Clozapine; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Excitatory Amino Acid Antagonists; Fluphenazine; Glucose; Haloperidol; PC12 Cells; Pimozide; Rats; Receptors, Dopamine D2; Spiperone; Sulpiride; Tritium | 1999 |
Chronic effect of antidopaminergic drugs or estrogen on male wistar rat lactotrophs and somatotrophs.
Topics: Animals; Dopamine Antagonists; Estrogens; Fluphenazine; Growth Hormone; Haloperidol; Hyperprolactinemia; Male; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Sulpiride | 1999 |
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Fluphenazine; Haloperidol; Hyperkinesis; Levodopa; Locomotion; Male; Naphthalenes; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Tetrahydronaphthalenes | 1999 |
Depot antipsychotics. Patient characteristics and prescribing pattern.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Utilization; Female; Flupenthixol; Fluphenazine; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Psychotic Disorders; Saudi Arabia; Surveys and Questionnaires | 2000 |
Sexual side effects of novel antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Clozapine; Erectile Dysfunction; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior | 2002 |
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prodrugs; Psychotic Disorders; Schizophrenia | 2002 |
Clozapine and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Longitudinal Studies; Schizophrenia, Paranoid | 2003 |
Rehospitalization risk with second-generation and depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Data Collection; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Patient Readmission; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention; Time Factors; Treatment Outcome | 2003 |
NOTES FROM THE LOG-BOOK OF A PSYCHOPHARMACOLOGICAL RESEARCH UNIT I.
Topics: Amobarbital; Behavior; Books; Chlordiazepoxide; Depression; Dextroamphetamine; Electroconvulsive Therapy; Fluphenazine; Haloperidol; Humans; Hyperthermia, Induced; Hypnotics and Sedatives; Lysergic Acid Diethylamide; Phenothiazines; Promazine; Psychopharmacology; Research; Speech Disorders; Thioridazine; Toxicology; Tranquilizing Agents | 1964 |
[EXPERIMENTAL EQUIVALENTS OF THE NEUROLOGIC SYNDROME OF NEUROLEPTICS].
Topics: Antipsychotic Agents; Catalepsy; Catatonia; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Neurologic Manifestations; Phenothiazines; Rats; Research; Reserpine; Syndrome | 1964 |
[LATENT NEURO-VEGETATIVE DISORDERS DURING CURES WITH NEUROLEPTICS. INCIDENTS AND ACCIDENTS IN CHILDREN AND ADOLESCENTS].
Topics: Accidents; Antipsychotic Agents; Child; Chlorpromazine; Cyanosis; Fluphenazine; Haloperidol; Humans; Hypotension; Hypothermia; Intellectual Disability; Methotrimeprazine; Phenothiazines; Tachycardia; Toxicology; Tranquilizing Agents | 1964 |
Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cohort Studies; Depressive Disorder; Diabetes Mellitus; Female; Fluphenazine; Glucose; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Retrospective Studies | 2003 |
Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer.
Topics: Capillary Action; Chemistry, Pharmaceutical; Flow Injection Analysis; Flupenthixol; Fluphenazine; Haloperidol; Infusions, Parenteral; Medroxyprogesterone Acetate; Rheology; Suspensions; Viscosity | 2004 |
THE USE OF HUMAN BIOASSAY PRINCIPLES IN GENERAL PRACTICE.
Topics: Biological Assay; Chlordiazepoxide; Drug Hypersensitivity; Fluphenazine; General Practice; Haloperidol; Humans; Meprobamate; Toxicology; Tranquilizing Agents | 1964 |
The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Brain; Clopenthixol; Clozapine; Dibenzothiazepines; Electric Impedance; Electroconvulsive Therapy; Electroencephalography; Electromyography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Seizures; Sulpiride | 2004 |
Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Chromones; Clozapine; Dibenzothiazepines; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Fluphenazine; Haloperidol; Humans; Morpholines; Nerve Growth Factor; Neurites; Olanzapine; PC12 Cells; Pertussis Toxin; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quetiapine Fumarate; Rats | 2005 |
Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Chlorpromazine; Cohort Studies; Female; Fluphenazine; Haloperidol; Hospitals, Veterans; Humans; Hyperglycemia; Incidence; Male; Middle Aged; Olanzapine; Perphenazine; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Southeastern United States; Time Factors; Veterans | 2007 |
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
Topics: Administration, Oral; Adult; Alcoholism; Antipsychotic Agents; Black People; Cohort Studies; Comorbidity; Crime; Cross-Sectional Studies; Delayed-Action Preparations; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Illicit Drugs; Male; Middle Aged; Patient Readmission; Prospective Studies; Schizophrenia; Schizophrenia, Disorganized; Schizophrenic Psychology; Substance-Related Disorders; Treatment Outcome; United States; White People | 2007 |
Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Risperidone; Schizophrenia; Severity of Illness Index | 2007 |
Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Edema; Fatal Outcome; Fluphenazine; Haloperidol; Heart Arrest; Humans; Hyperglycemia; Hyponatremia; Inappropriate ADH Syndrome; Male; Mental Disorders; Olanzapine; Pancreatitis; Paroxetine; Polypharmacy; Selective Serotonin Reuptake Inhibitors | 2007 |
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dopamine D2 Receptor Antagonists; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Motivation; Neostriatum; Nucleus Accumbens; Olanzapine; Oxygen; Psychomotor Performance; Reaction Time; Receptors, Dopamine D2; Reward; Schizophrenia; Schizophrenic Psychology | 2008 |
Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Kaplan-Meier Estimate; Prospective Studies; Schizophrenia; Time Factors | 2008 |
Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
Topics: Administration, Oral; Adult; Age Factors; Ambulatory Care; Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Health Knowledge, Attitudes, Practice; Humans; Long-Term Care; Male; Middle Aged; Patient Compliance; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Yugoslavia | 2008 |
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia | 2009 |
The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Topics: Adult; Alleles; Antipsychotic Agents; Bipolar Disorder; Clozapine; Cytochrome P-450 CYP2D6; Dibenzothiazepines; Drug Therapy, Combination; Fluphenazine; Genetic Carrier Screening; Genotype; Haloperidol; Humans; Lithium Carbonate; Male; Neuroleptic Malignant Syndrome; Perazine; Polymorphism, Genetic; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Recurrence; Risperidone | 2010 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures.
Topics: Antipsychotic Agents; Cell Line; Clozapine; Fibroblasts; Fluphenazine; Haloperidol; Humans; Schizophrenia; Thioridazine; Toxoplasma; Toxoplasmosis; Trifluoperazine | 2011 |
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride | 2012 |
Perphenazine suspension: a new, old treatment, side effects and continuous use.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cholinergic Antagonists; Clinical Trials as Topic; Drug Compounding; Drug Delivery Systems; Female; Fluphenazine; Haloperidol; Hospitals, Psychiatric; Humans; Male; Movement Disorders; Olanzapine; Patient Discharge; Perphenazine; Risperidone; Suspensions; Treatment Outcome | 2012 |
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Neurologic Examination; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Surveys and Questionnaires; Tunisia | 2013 |
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia | 2013 |
Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma.
Topics: Antipsychotic Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluphenazine; Haloperidol; Humans; Perphenazine; Reproducibility of Results; Tandem Mass Spectrometry; Thiothixene; Time Factors | 2013 |
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome | 2013 |
Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Odorants; Psychiatric Status Rating Scales; Reward; Schizophrenia; Schizophrenic Psychology; Smell; Substance-Related Disorders | 2014 |
Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Fluphenazine; Haloperidol; Humans; Perphenazine; Tandem Mass Spectrometry; Thiothixene | 2016 |
Impulsivity moderates the effects of dopamine D2 and mixed D1-D2 antagonists in individuals with gambling disorder.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Dopamine D2 Receptor Antagonists; Double-Blind Method; Female; Fluphenazine; Gambling; Haloperidol; Humans; Impulsive Behavior; Male; Motivation; Receptors, Dopamine D1; Receptors, Dopamine D2; Reinforcement, Psychology | 2019 |
Characterization hiPSC-derived neural progenitor cells and neurons to investigate the role of NOS1AP isoforms in human neuron dendritogenesis.
Topics: Adaptor Proteins, Signal Transducing; Cells, Cultured; Clozapine; Dendrites; Drug Evaluation, Preclinical; Fluphenazine; Gene Expression Regulation; Glutamic Acid; Haloperidol; Humans; Induced Pluripotent Stem Cells; Ion Channels; Nerve Tissue Proteins; Neural Stem Cells; Neurons; Oligopeptides; Patch-Clamp Techniques; Protein Isoforms; Schizophrenia; Serine | 2020 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Risperidone; Schizophrenia; Tardive Dyskinesia | 2022 |
Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia | 2023 |
Priming effects of a slot machine game and amphetamine on probabilistic risk-taking in people with gambling disorder and healthy controls.
Topics: Amphetamine; Dextroamphetamine; Dopamine; Fluphenazine; Gambling; Haloperidol; Humans; Risk-Taking | 2023 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |